0001829126-22-014926.txt : 20220801 0001829126-22-014926.hdr.sgml : 20220801 20220801140930 ACCESSION NUMBER: 0001829126-22-014926 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adorbs Inc. CENTRAL INDEX KEY: 0001726822 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] IRS NUMBER: 823155323 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-56213 FILM NUMBER: 221123971 BUSINESS ADDRESS: STREET 1: 234 E BEECH ST CITY: LONG BEACH STATE: NY ZIP: 11561 BUSINESS PHONE: 5165442812 MAIL ADDRESS: STREET 1: 234 E BEECH ST CITY: LONG BEACH STATE: NY ZIP: 11561 10-Q 1 adorbsinc_10q.htm 10-Q
0001726822 false --12-31 2022 Q2 0001726822 2022-01-01 2022-06-30 0001726822 2022-08-01 0001726822 2022-06-30 0001726822 2021-12-31 0001726822 2022-04-01 2022-06-30 0001726822 2021-04-01 2021-06-30 0001726822 2021-01-01 2021-06-30 0001726822 us-gaap:CommonStockMember 2020-12-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001726822 us-gaap:RetainedEarningsMember 2020-12-31 0001726822 2020-12-31 0001726822 us-gaap:CommonStockMember 2021-03-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001726822 us-gaap:RetainedEarningsMember 2021-03-31 0001726822 2021-03-31 0001726822 us-gaap:CommonStockMember 2021-12-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001726822 us-gaap:RetainedEarningsMember 2021-12-31 0001726822 us-gaap:CommonStockMember 2022-03-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001726822 us-gaap:RetainedEarningsMember 2022-03-31 0001726822 2022-03-31 0001726822 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001726822 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001726822 2021-01-01 2021-03-31 0001726822 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001726822 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001726822 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001726822 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001726822 2022-01-01 2022-03-31 0001726822 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001726822 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001726822 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001726822 us-gaap:CommonStockMember 2021-06-30 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001726822 us-gaap:RetainedEarningsMember 2021-06-30 0001726822 2021-06-30 0001726822 us-gaap:CommonStockMember 2022-06-30 0001726822 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001726822 us-gaap:RetainedEarningsMember 2022-06-30 0001726822 2017-10-18 0001726822 adob:SprayMember 2022-02-10 0001726822 2022-02-10 0001726822 us-gaap:GoodwillMember 2022-01-01 2022-06-30 0001726822 us-gaap:FiniteLivedIntangibleAssetsMember 2022-01-01 2022-06-30 0001726822 adob:SprayMember 2022-01-01 2022-06-30 0001726822 adob:ExchangeAgreementMember 2022-01-01 2022-06-30 0001726822 adob:ExchangeAgreementMember 2022-06-30 0001726822 adob:SevenInvestorsMember 2022-04-01 2022-06-30 0001726822 adob:SevenInvestorsMember 2022-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2022

 

Or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission file number 333-222631

 

ADORBS INC
(Exact name of registrant as specified in its charter)

 

Nevada   82-3155323

(State or other jurisdiction of
incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

8742
(Primary Standard Industrial Classification Code Number)

 

36 Fourth Ave. N, Yorkton Saskatchewan, Canada   S3N 2V7
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (306) 563-4123

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes   ☒ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☐ Yes   ☒ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated Filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.) ☐ Yes   ☒ No

 

The number of shares outstanding of the registrant’s common stock as of August 1, 2022 was 75,000,000 shares.

 

DOCUMENTS INCORPORATED BY REFERENCE — NONE

 

 

 

 

 

 

ADORBS INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE SIX MONTHS ENDED JUNE 30, 2022 (UNAUDITED)

 

Part I – FINANCIAL INFORMATION    
       
Item 1. Consolidated financial statements (unaudited)   1
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   13
       
Item 3. Quantitative and Qualitative Disclosures about Market Risk   17
       
Item 4. Controls and Procedures   17
       
Part II – OTHER INFORMATION    
       
Item 1. Legal Proceedings   19
       
Item 1A. Risk Factors   19
       
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   19
       
Item 3. Defaults Upon Senior Securities   19
       
Item 4. Mine Safety Disclosures   19
       
Item 5. Other Information   19
       
Item 6. Exhibits   20
       
SIGNATURES   21

 

i

 

 

PART I FINANCIAL INFORMATION

 

Item 1. Consolidated financial statements.

 

Index to Consolidated financial statements

 

    Page
CONSOLIDATED FINANCIAL STATEMENTS:    
     
Consolidated Balance Sheets, June 30, 2022 (unaudited), and December 31, 2021   2
     
Unaudited Consolidated Statements of Operations for the Six Months Ended June 30, 2022, and 2021   3
     
Unaudited Consolidated Statements of Changes in Stockholders’ Deficit for the Six Months Ended June 30, 2022, and 2021   4
     
Unaudited Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2022, and 2021   5
     
Notes to the Unaudited Interim Consolidated Financial Statements   6

 

1

 

 

ADORBS INC.

Consolidated Balance Sheets

(Unaudited)

 

           
   June 30,   December 31, 
   2022   2021 
Assets          
Current assets          
Cash and cash equivalents  $82,529   $9,499 
Accounts receivable   1,457    - 
Inventory   40,642    - 
Prepaid and other assets   1,239    - 
Total current assets   125,867    9,499 
Goodwill   538,350    - 
Intangible assets   115,895    - 
Total assets  $780,112   $9,499 
           
Liabilities and Stockholders’ Deficit          
Current Liabilities          
Accrued payable and accrued liabilities  $36,284   $428 
Common stock payable   776,806    - 
Due to related parties   229,748    142,752 
Total current liabilities   1,042,838    143,180 
Government loans   31,040    - 
Total liabilities   1,073,878    143,180 
           
Stockholders’ Deficit          
Common stock, Par Value $0.001, 700,000,000 shares authorized, 75,000,000 and 23,889,500 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively   75,000    23,890 
Additional paid in capital   25,740    25,740 
Accumulated deficit   (377,835)   (183,311)
Accumulated other comprehensive loss   (16,671)   - 
Total stockholders’ deficit   (293,766)   (133,681)
Total liabilities and stockholders’ deficit  $780,112   $9,499 

 

The accompanying notes are an integral part of these financial statements

 

2

 

 

ADORBS INC.

Consolidated Statements of Operations

(Unaudited)

 

                     
   For the
Three Months Ended		   For the
Six Months Ended		 
   June 30,   June 30, 
   2022   2021   2022   2021 
Revenue, net                
Revenue, net  $69,811   $-    134,542      
Cost of sales   23,831    -    39,137    - 
Gross margin   45,980    -    95,405    - 
                     
Operating expenses                    
General and administrative expenses   53,338    19,085    101,246    33,343 
Professional fees   140,865    -    168,892    - 
Amortization of intangible assets   11,338    -    18,948    - 
Total operating expenses   205,541    19,085    289,086    33,343 
Loss from operations   (159,561)   (19,085)   (193,681)   (33,343)
                     
Other income (expenses)                    
Interest income (expense)   (843)   6    (843)   12 
Total other income (expenses), net   (843)   6    (843)   12 
Loss from operations before income taxes   (160,404)   (19,079)   (194,524)   (33,331)
Income tax expense   -    -    -    - 
Net Loss  $(160,404)  $(19,079)   (194,524)  $(33,331)
                     
Basic and diluted loss per share  $(0.00)  $(0.00)  $(0.00)  $(0.00)
                     
Weighted average number of shares outstanding   75,000,000    23,889,500    63,422,483    23,889,500 
                     
Comprehensive loss:                    
Net loss  $ (160,404)  $(19,079)  $(194,524)  $(33,331)
Foreign currency translation adjustment   (16,671)   -    (16,671)   - 
Comprehensive loss  $(177,075)  $(19,079)  $(211,195)  $(33,331)

 

The accompanying notes are an integral part of these financial statements

 

 

3

 

 

ADORBS INC.

Consolidated Statements of Changes in Shareholders’ Deficit

(Unaudited)

 

                               
              Accumulated        
   Common Stock   Additional
Paid-in		   Other
Comprehensive		   Accumulated   Total
Stockholders’		 
   Shares   Value   Capital   Income (loss)   Deficit   Deficit 
Balance, December 31, 2020   23,889,500   $23,890   $25,740   $-   $(137,513)  $(87,883)
                               
Net loss        -     -     -     (14,252)   (14,252)
                               
Balance, March 31, 2021   23,889,500   $23,890   $25,740   $-   $(151,765)  $(102,135)
                               
Net loss        -     -     -     (19,079)   (19,079)
                               
Balance, June 30, 2021   23,889,500   $23,890   $25,740   $-   $(170,844)  $(121,214)

 

              Accumulated        
   Common Stock   Additional
Paid-in		   Other
Comprehensive		   Accumulated   Total
Stockholders’		 
   Shares   Value   Capital   Income (loss)   Deficit   Deficit 
Balance, December 31, 2021   23,889,500   $23,890   $25,740   $-   $(183,311)  $(133,681)
                               
Shares issued with acquisition of MySpray   51,110,500    51,110     -    -          51,110 
                               
Net loss             -    -     (34,120)   (34,120)
                               
Balance, March 31, 2022   75,000,000   $75,000   $25,740   $-   $(217,431)  $(116,691)
                               
Change in exchange rates                  (16,671)       $(16,671)
                               
Net loss        -     -          (160,404)   (160,404)
                               
Balance, June 30, 2022   75,000,000   $75,000   $25,740    (16,671)  $(377,835)  $(293,766)

 

The accompanying notes are an integral part of these financial statements

 

4

 

 

ADORBS INC.

Consolidated Statements of Cash Flows

(Unaudited)

 

           
   For the
Six Months Ended		 
   June 30, 
   2022   2021 
Cash Flows From Operating Activities          
Net loss  $(194,524)  $(33,331)
Amortization of intangible assets   18,948      
Adjustments to reconcile net income to net cash provided by operating activities:   -      
Changes in operating assets and liabilities:          
Accounts receivable   (871)   - 
Prepaid expenses        - 
Inventory   (11,942)   - 
Accrued payable and accrued liabilities   (4,440)   6 
Net cash used in operating activities   (192,829)   (33,325)
           
Cash Flows from Investing Activities          
Acquisition of a business net of cash acquired   19,981    - 
Net cash provided by investing activities   19,981    - 
           
Cash Flows From Financing Activities          
Common stock payable   206,917      
Proceeds from related party loans   24,916    31,506 
Net cash provided by financing activities   231,833    31,506 
           
Effect of exchange rate rates on cash and cash equivalents   14,045      
Net (decrease) increase in cash and cash equivalents   73,030    (1,819)
Cash and cash equivalents, beginning of year   9,499    13,593 
Cash and cash equivalents, end of year  $82,529   $11,774 
           
Supplemental disclosure of cash flow information          
Cash paid for income tax expense  $-   $- 
Cash paid for interest expense  $-   $- 

 

The accompanying notes are an integral part of these financial statements

 

5

 

 

ADORBS INC.

NOTES TO (UNAUDITED) CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTH PERIODS ENDED JUNE 30, 2022 AND 2021

 

NOTE 1 – ORGANIZATION AND DESCRIPTION OF THE BUSINESS

 

Basis of Presentation and Organization

 

Adorbs Inc. is a Nevada corporation. Adorbs was formerly a developmental stage corporation formed to provide organic children’s clothing designed to be cute, comfortable, and trendy. The Company was incorporated under the laws of the State of Nevada on October 18, 2017. On that date, the Company was authorized to issue 75,000,000 shares of common stock at $0.001 par value.

 

On February 10, 2022, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with MySpray Therapeutics Inc. (“MySpray”), a Saskatchewan, Canadian corporation, Nichol Martinuik (“Martinuik”) and Rachel Martinuik (“R. Martinuik”), the sole officers, directors, and shareholders of MySpray, Qatar Consulting Inc. & Company (“Qatar”), Broadway Creative Consultants Corp. (“Broadway”), and David Lazar (“Lazar”), as the sole officer and director of the Company and the managing member of Activist Investing LLC (“Activist”). Under the Share Exchange Agreement, One Hundred Percent (100%) of the ownership interest of MySpray was exchanged for (i) 51,110,500 shares of common stock of the Company at the Closing, and (ii) an additional 569,889,500 shares of common stock of ADOB, to be issued upon the increase in authorized shares of common stock of ADOB to 700,000,000, each of which is to be issued to Martinuik, R. Martinuik, Qatar, Broadway, and Activist, pro-rata, in accordance with the Share Exchange Agreement. The former stockholders of MySpray will acquire a majority of the issued and outstanding common stock as a result of the share exchange transaction. The transaction has been accounted for as a recapitalization of the Company, whereby MySpray is the accounting acquirer.

 

Immediately after completion of such share exchange, the Company will have a total of 644,889,500 issued and outstanding shares, with authorized share capital for common share of 700,000,000.

 

Consequently, the Company has ceased to fall under the definition of a shell company as defined in Rule 12b-2 under the Exchange Act of 1934, as amended (the “Exchange Act”) and MySpray is now a wholly-owned subsidiary.

 

On May 5, 2022, the Company filed a Certificate of Amendment with the state of Nevada increasing its authorized shares from 75,000,000 to 700,000,000 shares of $0.001 par value common stock. None of the additional 569,889,500 shares issuable under the terms of the Share Agreement, have been issued.

 

The Company will be amending its articles of incorporation to change its name from Adorbs Inc. to Soul Biotechnology Corporation.

 

MySpray creates innovative and clinically developed products for the global natural health community in the areas of immune function, mental health, and pain management and is currently the license holder of 9 Natural Product Numbers (NPN) through the Natural and Non-prescription Health Products Directorate division of Health Canada.

 

MySpray is preparing to expand formulas to support clinical trials along with the licensing for research and development in the fields of mental health and the impact of treatment protocols with phytonutrients, medicinal mushrooms, and psychedelic compounds under our current “MyShrooms” brand. Also, MySpray is attempting end-to-end capabilities from substrate for growth, genetics, research, extraction, formulations, delivery, and distribution of the finished product. This could allow MySpray to maintain high-quality control and enable us to:

 

●Create formulations for clinical trials.

 

●Supply raw materials, standardized extracts, and medicinal compounds that are in high demand for ongoing academic research globally.

 

●Provide finished products direct to consumer.

 

●Offer white label manufacturing.

 

The Company’s year-end is December 31.

 

All figures presented in this report are in US dollars unless stated otherwise. 

 

6

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES

 

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with the FASB’s ASC, which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary MySpray Therapeutics Inc. All intercompany accounts and transactions are eliminated in consolidation.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements.

 

The Company expects to generate operating cash flow that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable.

 

The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all. 

 

Management’s Representation of Interim Consolidated financial statements

 

The accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual consolidated financial statements. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year.

 

Estimates

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these consolidated financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

 

7

 

 

Cash and Cash Equivalents

 

For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2022, and December 31, 2021, the on-hand cash balances were $82,529 and $9,499, respectively.

 

Inventory

 

Inventory, is stated at the lower of cost or net realizable value with cost determined under the first-in, first-out (“FIFO”) method. As of June 30, 2022, and December 31, 2021, inventory amounted to $40,642 and $-0-, respectively

 

Goodwill and Intangible Assets

 

Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks and product formulations. The useful life of these customer relationships is estimated to be three years.

 

Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess.

 

Revenue Recognition

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The guidance provided in Accounting Standards Codification (“ASC”) Topic 606 (“ASC 606”) requires entities to use a five-step model to recognize revenue by allocating the consideration from contracts to performance obligations on a relative standalone selling price basis. Revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASC 606 also includes Subtopic 340-40, Other Assets and Deferred Costs – Contracts with Customers, which requires the deferral of incremental costs of obtaining a contract with a customer.

 

Foreign Currency Translation

 

The functional and reporting currency of MySpray is the Canadian dollar. Monetary assets denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Average monthly rates are used to translate revenues and expenses.

 

8

 

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income for the respective periods.

 

Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods

 

Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods. Equity transactions are recorded at the historical rate when the transaction occurred. The resulting translation adjustment is reflected as accumulated other comprehensive income, a separate component of stockholders’ equity in the statement of stockholders’ equity.

 

Differences may arise in the amount of bad debt expense, depreciation expense and amortization expense reported in the Company’s operating results as compared to the corresponding change in the allowance for doubtful accounts, accumulated depreciation, and accumulated amortization, respectively, due to foreign currency translation. These translation adjustments are reflected in accumulated other comprehensive income, a separate component of the Company’s stockholders’ equity.

 

Long-lived assets

 

The Company accounts for its long-lived assets in accordance with Financial Accounting Standard Board (“FASB”) ASC 360-10, “Property, Plant and Equipment” which requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of an asset by estimating the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposal value.

 

Income Taxes

 

The Company accounts for income taxes pursuant to FASB ASC Topic 740, Income Taxes. Under FASB ASC Topic 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. The Company maintains a 100% valuation allowance with respect to deferred tax assets, therefore there are no deferred taxes on the Company’s Balance Sheet. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

 

Fair Value Measurement

 

The Company values its convertible notes and amounts due to related partings and short-term loans payable under FASB ASC 820 which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.

 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

 

9

 

 

The three levels of the fair value hierarchy are as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities, and listed equities.

 

Level 2 – Valuations for assets and liabilities that can be obtained from readily available pricing sources via independent providers for market transactions involving similar assets or liabilities. The Company’s principal markets for these securities are the secondary institutional markets, and valuations are based on observable market data in those markets.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The Company uses Level 3 to value its derivative instruments.

 

Employee Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718 Compensation-Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest, and will result in a charge to operations.

 

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

 

Subsequent Event

 

The Company evaluated subsequent events through the date when consolidated financial statements are issued for disclosure consideration.

 

Recent Accounting Pronouncements

 

There are no recent accounting pronouncements that have an impact on the Company’s operations

 

NOTE 3 – GOING CONCERN

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements. The Company has incurred significant operating losses since its inception. As of June 30, 2022, the Company had a working capital deficit of $916,971 and an accumulated deficit of $377,835.

 

The Company expects to generate operating cash flows that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable.

 

The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all.

 

10

 

 

NOTE 4 – BUSINESS ACQUISITION

 

On February 10, 2022, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with MySpray Therapeutics Inc. (“MySpray”), a Saskatchewan, Canadian corporation, Nichol Martinuik (“Martinuik”) and Rachel Martinuik (“R. Martinuik”), the sole officers, directors, and shareholders of MySpray, Qatar Consulting Inc. & Company (“Qatar”), Broadway Creative Consultants Corp. (“Broadway”), and David Lazar (“Lazar”), as the sole officer and director of the Company and the managing member of Activist Investing LLC (“Activist”). Under the Share Exchange Agreement, One Hundred Percent (100%) of the ownership interest of MySpray was exchanged for (i) 51,110,500 shares of common stock of the Company at the Closing, and (ii) an additional 569,889,500 shares of common stock of ADOB, to be issued upon the increase in authorized shares of common stock of ADOB to 700,000,000, each of which is to be issued to Martinuik, R. Martinuik, Qatar, Broadway, and Activist, pro-rata, in accordance with the Share Exchange Agreement. As of the date of this Report, none of the 569,889,500 shares had been issued. The former stockholders of MySpray will acquire a majority of the issued and outstanding common stock as a result of the share exchange transaction. The transaction has been accounted for as a recapitalization of the Company, whereby MySpray is the accounting acquirer.

 

For the acquisition of MySpray the following table summarizes the acquisition date fair value of the consideration paid, identifiable assets acquired and liabilities assumed:

 

Consideration paid

 

     
Common stock, 621,000,000 shares of the Company restricted common stock valued at $0.001 per share  $621,000 
Net liabilities assumed   62,777 
Fair value of total consideration paid  $683,777 

 

Net assets acquired and liabilities assumed

 

      
Cash and cash equivalents  $30,542 
Accounts receivable   595 
Inventory   53,431 
Other assets   1,409 
Total assets  $85,977 
      
Accounts payable and accrued liabilities   117,214 
Government of Canada loan   31,540 
Total liabilities   148,754 
      
Net liabilities assumed  $62,777 

 

The Company has allocated the fair value of the total consideration paid of $547,022 to goodwill and $136,755 to intangible assets with a life of three years. The value of goodwill represents MySpray’s ability to generate profitable operations going forward. Management estimated the provisional fair values of the intangible assets and goodwill at December 31, 2021. The Company’s accounting for the acquisition of MySpray is incomplete. Management is performing a valuation study to calculate the fair value of the acquired intangible assets, which it plans to complete within the one-year measurement period.

 

NOTE 5 – INTANGIBLE ASSETS

 

As of June 30, 2022, the balance of intangible assets was $115,895. During the six-month period ended June 30, 2022, the Company recorded $18,948 in amortization expense. As discussed in Note 4, the intangible assets have been valued based on provisional estimates of fair value and are subject to change as the Company completes its valuation assessment by the completion of the one-year measurement period. Amortization for the following fiscal years is estimated to be: 2022 - $36,414; 2023 - $43,697; and 2024 - $43,697, 2025 -$14,983.

 

11

 

 

NOTE 6 – RELATED PARTY TRANSACTIONS

 

The Company has been funded by its executive officers, and officers of its subsidiary. As of June 30, 2022, the balance due to executive officers and a former officer amounted to $299,748 in the form of interest-free demand loans compared to $142,752 during the period ended December 31, 2021. During the six months ended June 30, 2022, the Company’s officers have advanced $24,916 to the Company.

 

Additionally, an officer of MySpray owns the laboratory building that the Company occupies. He rents this facility to MySpray based on a verbal, month-to-month agreement. MySpray pays approximately $26,000 annually in rent. The Company believes that this rent expense is reasonable and comparable to the rent that would be charged to a third party.

 

NOTE 7 – COMMON STOCK AND COMMON STOCK PAYABLE

 

On May 5, 2022, the Company filed a Certificate of Amendment with the state of Nevada increasing its authorized shares from 75,000,000 to 700,000,000 shares of $0.001 par value common stock. As of June 30, 2022, and December 31, 2021, a total of 75,000,000 and 23,889,500 shares of common stock were issued and outstanding, respectively.

 

As of the date of this report, the Company had numerous shares issuable as part of the February 10, 2022 Share Exchange and for private placements accepted from investors during the three months ended June 30, 2022. Since the Company has delayed issuing these shares the associated value of the shares has been recorded as a liability on the Company’s, Balance sheet. As of June 30, 2022 and December 31, 2021 the balance of Common Stock Payable was $776,806 and $-0-, respectively.

 

The amount of $776,806 is comprised of the following elements:

 

●569,889,500 shares are issuable pursuant to the terms of the share Exchange Agreement. These shares were valued at a par value of $0.001, or $569,899

 

●During the three months ended June 30, 2022 the Company raised $369,978 from sale of 21,000,000 shares to seven investors. The average sale price of these shares was $0.017618 per share

 

●Additionally, the Company repurchased 24,000,000 shares for $103,333, or an average price of $0.00431

 

None of the above mentioned shares have been issued or retired as of June 30, 2022

 

NOTE 8 – SUBSEQUENT EVENTS

 

In accordance with the Statement of Financial Accounting Standards (“SFAS”) 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the consolidated financial statements were available to be issued and has determined that it does not have any material subsequent events to disclose in these consolidated financial statements.

 

12

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis should be read in conjunction with our unaudited consolidated financial statements and the related notes thereto. The management’s discussion and analysis contains forward-looking statements, such as statements of our plans, objectives, expectations, and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q. The following discussion should be read in conjunction with our audited financial statements and the related notes that appear in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 30, 2022.

 

Overview

 

Business Overview

 

Adorbs Inc. is a US holding company incorporated in Nevada in October 2017, which operates through the Company’s wholly owned subsidiary MySpray Therapeutics Inc. (“MySpray”), a Saskatchewan, Canada corporation incorporated on October 2, 2012.

 

MySpray creates innovative and clinically developed products for the global natural health community in the areas of immune function, mental health, and pain management.

 

MySpray Therapeutics® Inc. is currently the license holder of 9 Natural Product Numbers (NPN) through the Natural and Non-prescription Health Products Directorate division of Health Canada.

 

We are preparing to expand formulas to support clinical trials along with the licensing for research and development in the fields of mental health and the impact of treatment protocols with phytonutrients, medicinal mushrooms, and psychedelic compounds under our current “MyShrooms” brand.

 

We are attempting end-to-end capabilities from substrate for growth, genetics, research, extraction, formulations, delivery, and distribution of the finished product. This could allow MySpray to maintain high-quality control and enable us to:

 

●Create formulations for clinical trials.

 

●Supply raw materials, standardized extracts, and medicinal compounds that are in high demand for ongoing academic research globally.

 

●Provide finished products direct to consumer.

 

●Offer white label manufacturing.

 

Through this process, we are attempting to achieve a net zero global environmental footprint, implementing growth solutions using naturally composted substrates and by-products of manufacturing current products. MySpray is a current member of the Canadian Health Food Association (CHFA) and presently offers 5 products in the natural health marketplace, and proudly manufactures in Canada with cGMP credentials, sourced from USDA-certified organic North American producers.

 

MySpray is clinically developing innovative and evidence-based therapeutics that can help us generate revenue through the sales of its five products to distributors, direct wholesale to pharmacies, clinics, health stores, ecommerce and traditional retailers, along with our retail online store.

 

13

 

 

Background of the Company

 

MySpray Therapeutics was founded in 2012 by natural health practitioner and researcher, Nichol Martinuik, with a mission of creating the most innovative and life-changing products.

 

The first mission was to find a solution to the low absorption rates of nutrients from pills, leading to the development of Vitamin D3 and B12 oral sprays. Sublingual and buccal absorption provides a much higher absorption by the body, eliminating the gastric breakdown through digestion. With the use of a convenient spray, it ensures that your body is receiving the maximum benefits.

 

MyPain LiniMint was the next product to be approved by Health Canada, after many years of clinical research and development with dimethyl sulfoxide (“DMSO”) as a topical analgesic for pain management. DMSO provides tissue penetration directly to the site of pain and inflammation, with capabilities beyond any other topically applied product. Many trials were conducted with this formula to create a balanced product that minimized the odors associated with DMSO.

 

MyShrooms Immunity was then developed as an immune modulator and formulated with a synergistic blend of 8 medicinal mushrooms. Fungi have been revered medically for thousands of years in their abilities to increase the immune system’s recognition and defence from daily threats. MyShrooms Defence is the evolution of the original Vitamin D3 spray, and a combination of Chaga and D3. Chaga is a potent substance containing over 200 nutrients, including vitamin D and the cofactors necessary for absorption, creating a superior formula for disease prevention.

 

MySpray is committed to ongoing research, and the development of innovative solutions and premium health products. Nichol is a member of the Natural Health Practitioners of Canada, and the Saskatchewan Association of Doctors of Natural Medicine. MySpray Therapeutics is proudly manufactured in Canada and a proud member of the Canadian Health Food Association.

 

Products

 

MySpray offers products in a variety of delivery systems including topical, capsules, and through a highly absorbed convenient oral spray delivery system.

 

MyShrooms Immune-Pro

MyShrooms Immune-Pro is a clinical strength herbal medicine to activate, balance, and support a healthy immune system. It is formulated with a powerful and unique trifecta of medicinal mushrooms, ginseng, and propolis. With potent antioxidants and powerful adaptogens it increases energy and the body’s response to stress, along with related mental and physical fatigue.

 

MyShrooms Defence

MyShrooms Defence is a combination of chaga, often proclaimed “king of medicinal mushrooms,” and Vitamin D. Chaga is a rich source of potent antioxidants and powerful phytochemicals, such as sterols, phenols, beta-glucans, and melanin. Vitamin D, widely known as the sunshine vitamin, is an essential hormone for disease prevention, and the regulation of minerals. Combined they strengthen the body’s natural defence system, and protect against pathogens, illness and disease.

 

MyShrooms Immunity

MyShrooms Immunity offers the synergistic effect of 8 medicinal mushrooms, each containing complex, unique and specific compounds providing significant health benefits throughout the whole body. As an immune modulator, it helps to activate, balance and restore a healthy immune response with a comprehensive combination of the most potent medicinal mushrooms including: Reishi, Chaga, Cordyceps, Turkey Tail, Lion’s Mane, Agaricus Blazei, Shiitake, and Maitake.

 

MyShrooms Energy

MyShrooms Energy is a combination of Cordyceps and Vitamin B12. Cordyceps mushroom has been used for centuries for its energizing and apoptogenic properties, as well as to support oxygen uptake, stamina, endurance, libido, and kidney and adrenal health. With naturally occurring B-vitamins, it is a perfect blend to include Vitamin B12 with its essential and diverse functions in the body. B12 is involved in the maintenance of the nervous system, red blood cell production, energy metabolism and the proper functioning of our brain, heart, liver, and kidneys. Combined they contribute to optimal health, well-being, performance, mood, vitality and energy.

 

14

 

 

MyPain LiniMint

MyPain LiniMint contains 80% DMSO and delivers the deepest tissue penetration available. It is 100% natural and provides unmatched pain relief from muscle strains, joint sprains, backaches & arthritis. The powerful analgesic properties easily penetrate through the skin into all tissues, reducing pain and inflammation at the source to promote the body’s natural healing process, a remarkable advantage over other topically applied products.

 

With approximately 11,000 studies on DMSO, research demonstrates its analgesic properties by blocking the peripheral C nerve fibers and acts as an antioxidant neutralizing the free radicals of inflammation.

 

MySpray generates revenue through the sales of its five products to distributors, direct wholesale to pharmacies, clinics, health stores, ecommerce and traditional retailers, along with our retail online store.

 

Results of Operations for the Three Months and Six Months Ended June 30, 2022 Compared to the Three and Six Months Ended June 30, 2021

 

Revenue

 

For the six months ended June 30, 2022, we recorded $134,542 in revenue from the sale of our product compared to $-0- for the six months ended June 30, 2021, since we were a shell corporation at that time. We are in the process of developing our strategic business plan going forward and, therefore, revenues may vary from period to period.

 

Cost of sales

 

Cost of sales was $39,137 for the six months ended June 30, 2022, compared to cost of sales of $-0- for the six months ended June 30, 2021

 

Operating expenses

 

Operating expenses for the six months ended June 30, 2022 were $289,085 compared to $33,343 for the six months ended June 30, 2021. The significant increase in operating expenses in the six months ended June 30, 2022, compared to the same period in 2021 is due to the acquisition of MySpray during the 2022 period compared to no activity in 2022. The $289,085 in operating expenses is comprised of $101,246 in general and administrative expense, $168,892, in legal, accounting and consulting fees, and $18,948 from the amortization of intangible assets

 

As a result of the foregoing, we had a loss of $194,524 for the six months ended June 30, 2022 compared to a loss of $33,331 during the same six-month period ended June 30, 2021.

 

Liquidity and Capital Resources

 

We had $82,529 in cash on hand as of June 30, 2022.

 

Net cash used in operating activities was $192,829 for the six months ended June 30, 2022, compared to $33,331 for the six months ended June 30, 2021. The increase in cash used in operating activities during the six months ended June 30, 2022 was primarily due to increased losses in the 2022 period over 2021 levels.

 

Net cash provided by financing activities was $231,832 for the six months ended June 30, 2022, compared to $31,506 for the six months ended June 30, 2021. The increase during the 2022 period is primarily attributable to the private placement of shares, net of shares repurchased amounting to $206,917 compared to $-0- in the prior period

 

We believe will become cash flow positive from operations in the future, however, there can be no assurance that we will be successful. Also, there can be no assurance that related parties will continue to fund our operations or that we can obtain funding from the sale of our securities or through the issuance of debt.

 

15

 

 

Financial Impact of COVID-19

 

The COVID-19 pandemic has affected how we are operating our business, and the duration and extent to which this will impact our future results of operations and overall financial performance remains uncertain. The COVID-19 pandemic is having widespread, rapidly evolving, and unpredictable impacts on global society, economies, financial markets, and business practices. Federal, state and foreign governments have implemented measures to contain the virus, including social distancing, travel restrictions, border closures, limitations on public gatherings, work from home, and closure of non-essential businesses. To protect the health and well-being of our employees, partners, and third-party service providers, we have implemented work-from-home requirements, made substantial modifications to employee travel policies, and cancelled or shifted marketing and other corporate events to virtual-only formats for the foreseeable future. While we continue to monitor the situation and may adjust our current policies as more information and public health guidance become available, such precautionary measures could negatively affect our customer success efforts, sales and marketing efforts, delay and lengthen our sales cycles, or create operational or other challenges, any of which could harm our business and results of operations. In addition, the COVID-19 pandemic has disrupted the operations of our current enterprise customers, as well as many potential enterprise customers, and may continue to disrupt their operations, for an indefinite period of time, including as a result of travel restrictions and/or business shutdowns, uncertainty in the financial markets, or other harm to their businesses and financial results, resulting in delayed purchasing decisions, extended payment terms, and postponed or cancelled projects, all of which could negatively impact our business and results of operations, including our revenue and cash flows.

 

Beginning in March 2020, the U.S., Canadian and global economies have reacted negatively in response to worldwide concerns due to the economic impacts of the COVID-19 pandemic. These factors also may adversely impact enterprise and government spending on technology as well as such customers’ ability to pay for our products and services on an ongoing basis. For example, some businesses in industries particularly impacted by the COVID-19 pandemic, such as travel, hospitality, retail, and oil and gas, have significantly cut or eliminated capital expenditures. A prolonged economic downturn could adversely affect technology spending, demand for our offerings, which could have a negative impact on our financial condition, results of operations and cash flows. Any resulting instability in the financial markets could also adversely affect the value of our common stock, our ability to refinance our indebtedness, and our access to capital.

 

The ultimate duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately forecasted at this time, such as the severity and transmission rate of the disease, the actions of governments, businesses and individuals in response to the pandemic, the extent and effectiveness of containment actions, the impact on economic activity and the impact of these and other factors on our employees, partners, and third-party service providers. These uncertainties may increase variability in our future results of operations and adversely impact our ability to accurately forecast changes in our business performance and financial condition in future periods. If we are not able to respond to and manage the impact of such events effectively or if global economic conditions do not improve, or deteriorate further, our business, financial condition, results of operations, and cash flows could be adversely affected.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

We believe that the following critical policies affect our more significant judgments and estimates used in preparation of our consolidated financial statements.

 

See Note 2 to the Financial Statements for a Listing of our Critical Accounting Policies

 

16

 

 

New Accounting Pronouncements

 

There are no new accounting pronouncement that have a material impact on our financial statements.

 

Off-Balance Sheet Arrangements

 

None.

 

Item 3. Quantitative And Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company and are not required to provide this information.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures.

 

Our management is responsible for establishing and maintaining a system of “disclosure controls and procedures” (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our disclosure controls and procedures were not effective as of June 30, 2022

 

Management’s Report on Internal Control over Financial Reporting.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

 

  ● pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
     
  ● provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
     
  ● provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.

 

Our management assessed the effectiveness of our internal control over financial reporting based on the parameters set forth above and has concluded that as of June 30, 2022, our internal control over financial reporting was not effective to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with U.S. generally accepted accounting principles as a result of the following material weaknesses:

 

17

 

 

  ● The Company does not have sufficient segregation of duties within accounting functions due to only having one officer and limited resources.

 

  ● The Company does not have an independent board of directors or an audit committee.
     
  ● The Company does not have written documentation of our internal control policies and procedures.
     
  ● All of the Company’s financial reporting is carried out by a financial consultant.

 

We plan to rectify these weaknesses by implementing an independent board of directors, establishing written policies and procedures for our internal control of financial reporting, and hiring additional accounting personnel at such time as we complete a reverse merger or similar business acquisition.

 

Changes in Internal Control over Financial Reporting.

 

There has been no change in our internal control over financial reporting during the year June 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

18

 

 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

The Company may be involved in certain legal proceedings that arise from time to time in the ordinary course of its business. Legal expenses associated with any contingency are expensed as incurred. The Company’s officers and directors are not aware of any threatened or pending litigation to which the Company is a party or which any of its property is the subject and which would have any material, adverse effect on the Company.

 

Item 1A. Risk Factors.

 

As a smaller reporting company, we are not required to include this disclosure in this Quarterly Report on Form 10-Q. 

 

Item 2. Unregistered Sales of Equity Securities and Use Of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

19

 

 

Item 6. Exhibits.

 

The exhibits listed on the Exhibit Index below are provided as part of this report.

 

3.1   Articles of Incorporation of the Company Inc., as amended on March 16, 2018 (incorporated by reference to our Registration Statement on Form S-1 filed on January 19, 2018)
     
3.2   Bylaws of the Company Inc. (incorporated by reference to our Registration Statement on Form S-1 filed on January 19, 2018)
     
10.1   Share Exchange Agreement (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 10, 2022
     
22   Demand Promissory Note Payable to Activist Investing LLC (incorporated by reference to our Registration Statement on 10-12G/A filed on December 22, 2020)
     
23   Demand Promissory Note Payable to Rebecca Lazar (incorporated by reference to our Registration Statement on 10-12G/A filed on December 22, 2020)
     
31.1   Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)
     
32.1   Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Schema Document
     
101.CAL   XBRL Calculation Linkbase Document
     
101.DEF   XBRL Definition Linkbase Document
     
101.LAB   XBRL Label Linkbase Document
     
101.PRE   XBRL Presentation Linkbase Document

 

20

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ADORBS INC.
     
Dated: August 1, 2022 By: /s/ David Lazar
    David Lazar
    Chief Executive Officer and
    Chief Financial Officer
    Principal Executive Officer,
    Principal Financial Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

21

 EX-31.1 2 adorbsinc_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

 

I, David Lazar, certify that:

 

1. I have reviewed this Quarterly report on Form 10-Q of ADORBS INC;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of a quarter report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: August 1, 2022 By: /s/ David Lazar
   

David Lazar

Chief Executive Officer

(Principal Executive Officer and
Principal Financial Officer)

 

 

 EX-32.1 3 adorbsinc_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of ADORBS INC. (the “Company”) on Form 10-Q for the quarter ended June 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David Lazar, Chief Executive Officer, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

Dated: August 1, 2022 By: /s/ David Lazar
   

David Lazar

Chief Executive Officer

(Principal Executive Officer and
Principal Financial Officer)

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 EX-101.CAL 4 adob-20220630_cal.xml XBRL CALCULATION FILE EX-101.DEF 5 adob-20220630_def.xml XBRL DEFINITION FILE EX-101.LAB 6 adob-20220630_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Business Acquisition [Axis] Spray [Member] Asset Class [Axis] Goodwill [Member] Finite-Lived Intangible Assets [Member] Related Party [Axis] Transaction Type [Axis] Exchange Agreement [Member] Title of Individual [Axis] Seven Investors [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current assets Cash and cash equivalents Accounts receivable Inventory Prepaid and other assets Total current assets Goodwill Intangible assets Total assets Liabilities and Stockholders’ Deficit Current Liabilities Accrued payable and accrued liabilities Common stock payable Due to related parties Total current liabilities Government loans Total liabilities Stockholders’ Deficit Common stock, Par Value $0.001, 700,000,000 shares authorized, 75,000,000 and 23,889,500 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively Additional paid in capital Accumulated deficit Accumulated other comprehensive loss Total stockholders’ deficit Total liabilities and stockholders’ deficit Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares Outstanding Income Statement [Abstract] Revenue, net Revenue, net Cost of sales Gross margin Operating expenses General and administrative expenses Professional fees Amortization of intangible assets Total operating expenses Loss from operations Other income (expenses) Interest income (expense) Total other income (expenses), net Loss from operations before income taxes Income tax expense Net Loss Basic and diluted loss per share Weighted average number of shares outstanding Comprehensive loss: Net loss Foreign currency translation adjustment Comprehensive loss Statement [Table] Statement [Line Items] Beginning balance, value Beginnig balance, shares Change in exchange rates Shares issued with acquisition of MySpray Shares issued with acquisition of MySpray, Shares Net loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities Net loss Adjustments to reconcile net income to net cash provided by operating activities: Changes in operating assets and liabilities: Accounts receivable Prepaid expenses Inventory Accrued payable and accrued liabilities Net cash used in operating activities Cash Flows from Investing Activities Acquisition of a business net of cash acquired Net cash provided by investing activities Cash Flows From Financing Activities Common stock payable Proceeds from related party loans Net cash provided by financing activities Effect of exchange rate rates on cash and cash equivalents Net (decrease) increase in cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Supplemental disclosure of cash flow information Cash paid for income tax expense Cash paid for interest expense Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND DESCRIPTION OF THE BUSINESS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES GOING CONCERN Business Combination and Asset Acquisition [Abstract] BUSINESS ACQUISITION Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Common Stock And Common Stock Payable COMMON STOCK AND COMMON STOCK PAYABLE Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation Going Concern Management’s Representation of Interim Consolidated financial statements Estimates Cash and Cash Equivalents Inventory Goodwill and Intangible Assets Revenue Recognition Foreign Currency Translation Long-lived assets Income Taxes Fair Value Measurement Employee Stock-Based Compensation Net Loss per Share Subsequent Event Recent Accounting Pronouncements Schedule of cosideration paid Schedule of asset and liabilities assumed Schedule of Restructuring and Related Costs [Table] Restructuring Cost and Reserve [Line Items] Ownership interest Common stock at Closing Common stock to be issued Increase in common stock shares authorized Number of shares issued Number of shares outstanding Share authorized for capital stock Cash in hand balance Working capital deficit Accumulated deficit Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Common stock, 621,000,000 shares of the Company restricted common stock valued at $0.001 per share Net liabilities assumed Fair value of total consideration paid Cash and cash equivalents Accounts receivable Inventory Other assets Total assets Accounts payable and accrued liabilities Government of Canada loan Total liabilities Fair value of consideration Amortization expense 2022 2023 2024 2025 Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Due to related party Proceed from related party debt Rent payment Offsetting Assets [Table] Offsetting Assets [Line Items] Number of stock issuable, shares Share price Number of stock issuable, value Number of stock sold, value Number of stock sold, shares Number of stock repurchased, shares Number of stock repurchased, value Working capital deficit. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Net Income (Loss) Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss) Available to Common Stockholders, Basic Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Businesses, Net of Cash Acquired Net Cash Provided by (Used in) Investing Activities ProceedsFromCommonStockPayable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Inventory, Policy [Policy Text Block] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory EX-101.PRE 7 adob-20220630_pre.xml XBRL PRESENTATION FILE EX-101.SCH 8 adob-20220630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF THE BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - BUSINESS ACQUISITION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - COMMON STOCK AND COMMON STOCK PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - BUSINESS ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - ORGANIZATION AND DESCRIPTION OF THE BUSINESS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - BUSINESS ACQUISITION (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - BUSINESS ACQUISITION (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - BUSINESS ACQUISITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - COMMON STOCK AND COMMON STOCK PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover - shares
 6 Months Ended
Jun. 30, 2022
Aug. 01, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2022  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 333-222631  
Entity Registrant Name ADORBS INC  
Entity Central Index Key 0001726822  
Entity Tax Identification Number 82-3155323  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 36 Fourth Ave. N  
Entity Address, City or Town Yorkton Saskatchewan  
Entity Address, Country CA  
Entity Address, Postal Zip Code S3N 2V7  
City Area Code 306  
Local Phone Number 563-4123  
Entity Current Reporting Status No  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   75,000,000
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 82,529 $ 9,499
Accounts receivable 1,457
Inventory 40,642 (0)
Prepaid and other assets 1,239
Total current assets 125,867 9,499
Goodwill 538,350
Intangible assets 115,895
Total assets 780,112 9,499
Current Liabilities    
Accrued payable and accrued liabilities 36,284 428
Common stock payable 776,806 (0)
Due to related parties 229,748 142,752
Total current liabilities 1,042,838 143,180
Government loans 31,040
Total liabilities 1,073,878 143,180
Stockholders’ Deficit    
Common stock, Par Value $0.001, 700,000,000 shares authorized, 75,000,000 and 23,889,500 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 75,000 23,890
Additional paid in capital 25,740 25,740
Accumulated deficit (377,835) (183,311)
Accumulated other comprehensive loss (16,671)
Total stockholders’ deficit (293,766) (133,681)
Total liabilities and stockholders’ deficit $ 780,112 $ 9,499
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2022
Dec. 31, 2021
Oct. 18, 2017
Statement of Financial Position [Abstract]      
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001 $ 0.001
Common stock, shares authorized 700,000,000 700,000,000 75,000,000
Common stock, shares issued 75,000,000 23,889,500  
Common stock, shares Outstanding 75,000,000 23,889,500  
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue, net        
Revenue, net $ 69,811 $ 134,542  
Cost of sales 23,831 39,137
Gross margin 45,980 95,405
Operating expenses        
General and administrative expenses 53,338 19,085 101,246 33,343
Professional fees 140,865 168,892
Amortization of intangible assets 11,338 18,948
Total operating expenses 205,541 19,085 289,086 33,343
Loss from operations (159,561) (19,085) (193,681) (33,343)
Other income (expenses)        
Interest income (expense) (843) 6 (843) 12
Total other income (expenses), net (843) 6 (843) 12
Loss from operations before income taxes (160,404) (19,079) (194,524) (33,331)
Income tax expense
Net Loss $ (160,404) $ (19,079) $ (194,524) $ (33,331)
Basic and diluted loss per share $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average number of shares outstanding 75,000,000 23,889,500 63,422,483 23,889,500
Comprehensive loss:        
Net loss $ (160,404) $ (19,079) $ (194,524) $ (33,331)
Foreign currency translation adjustment (16,671) (16,671)
Comprehensive loss $ (177,075) $ (19,079) $ (211,195) $ (33,331)
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 23,890 $ 25,740 $ (137,513) $ (87,883)
Beginnig balance, shares at Dec. 31, 2020 23,889,500        
Net loss (14,252) (14,252)
Ending balance, value at Mar. 31, 2021 $ 23,890 25,740 (151,765) (102,135)
Ending balance, shares at Mar. 31, 2021 23,889,500        
Net loss (19,079) (19,079)
Ending balance, value at Jun. 30, 2021 $ 23,890 25,740 (170,844) (121,214)
Ending balance, shares at Jun. 30, 2021 23,889,500        
Beginning balance, value at Dec. 31, 2021 $ 23,890 25,740 (183,311) (133,681)
Beginnig balance, shares at Dec. 31, 2021 23,889,500        
Shares issued with acquisition of MySpray $ 51,110   51,110
Shares issued with acquisition of MySpray, Shares 51,110,500        
Net loss   (34,120) (34,120)
Ending balance, value at Mar. 31, 2022 $ 75,000 25,740 (217,431) (116,691)
Ending balance, shares at Mar. 31, 2022 75,000,000        
Change in exchange rates     (16,671)   (16,671)
Net loss   (160,404) (160,404)
Ending balance, value at Jun. 30, 2022 $ 75,000 $ 25,740 $ (16,671) $ (377,835) $ (293,766)
Ending balance, shares at Jun. 30, 2022 75,000,000        
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows From Operating Activities    
Net loss $ (194,524) $ (33,331)
Amortization of intangible assets 18,948
Changes in operating assets and liabilities:    
Accounts receivable (871)
Prepaid expenses  
Inventory (11,942)
Accrued payable and accrued liabilities (4,440) 6
Net cash used in operating activities (192,829) (33,325)
Cash Flows from Investing Activities    
Acquisition of a business net of cash acquired 19,981
Net cash provided by investing activities 19,981
Cash Flows From Financing Activities    
Common stock payable 206,917  
Proceeds from related party loans 24,916 31,506
Net cash provided by financing activities 231,833 31,506
Effect of exchange rate rates on cash and cash equivalents 14,045  
Net (decrease) increase in cash and cash equivalents 73,030 (1,819)
Cash and cash equivalents, beginning of year 9,499 13,593
Cash and cash equivalents, end of year 82,529 11,774
Supplemental disclosure of cash flow information    
Cash paid for income tax expense
Cash paid for interest expense
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.22.2
ORGANIZATION AND DESCRIPTION OF THE BUSINESS
 6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND DESCRIPTION OF THE BUSINESS

NOTE 1 – ORGANIZATION AND DESCRIPTION OF THE BUSINESS

 

Basis of Presentation and Organization

 

Adorbs Inc. is a Nevada corporation. Adorbs was formerly a developmental stage corporation formed to provide organic children’s clothing designed to be cute, comfortable, and trendy. The Company was incorporated under the laws of the State of Nevada on October 18, 2017. On that date, the Company was authorized to issue 75,000,000 shares of common stock at $0.001 par value.

 

On February 10, 2022, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with MySpray Therapeutics Inc. (“MySpray”), a Saskatchewan, Canadian corporation, Nichol Martinuik (“Martinuik”) and Rachel Martinuik (“R. Martinuik”), the sole officers, directors, and shareholders of MySpray, Qatar Consulting Inc. & Company (“Qatar”), Broadway Creative Consultants Corp. (“Broadway”), and David Lazar (“Lazar”), as the sole officer and director of the Company and the managing member of Activist Investing LLC (“Activist”). Under the Share Exchange Agreement, One Hundred Percent (100%) of the ownership interest of MySpray was exchanged for (i) 51,110,500 shares of common stock of the Company at the Closing, and (ii) an additional 569,889,500 shares of common stock of ADOB, to be issued upon the increase in authorized shares of common stock of ADOB to 700,000,000, each of which is to be issued to Martinuik, R. Martinuik, Qatar, Broadway, and Activist, pro-rata, in accordance with the Share Exchange Agreement. The former stockholders of MySpray will acquire a majority of the issued and outstanding common stock as a result of the share exchange transaction. The transaction has been accounted for as a recapitalization of the Company, whereby MySpray is the accounting acquirer.

 

Immediately after completion of such share exchange, the Company will have a total of 644,889,500 issued and outstanding shares, with authorized share capital for common share of 700,000,000.

 

Consequently, the Company has ceased to fall under the definition of a shell company as defined in Rule 12b-2 under the Exchange Act of 1934, as amended (the “Exchange Act”) and MySpray is now a wholly-owned subsidiary.

 

On May 5, 2022, the Company filed a Certificate of Amendment with the state of Nevada increasing its authorized shares from 75,000,000 to 700,000,000 shares of $0.001 par value common stock. None of the additional 569,889,500 shares issuable under the terms of the Share Agreement, have been issued.

 

The Company will be amending its articles of incorporation to change its name from Adorbs Inc. to Soul Biotechnology Corporation.

 

MySpray creates innovative and clinically developed products for the global natural health community in the areas of immune function, mental health, and pain management and is currently the license holder of 9 Natural Product Numbers (NPN) through the Natural and Non-prescription Health Products Directorate division of Health Canada.

 

MySpray is preparing to expand formulas to support clinical trials along with the licensing for research and development in the fields of mental health and the impact of treatment protocols with phytonutrients, medicinal mushrooms, and psychedelic compounds under our current “MyShrooms” brand. Also, MySpray is attempting end-to-end capabilities from substrate for growth, genetics, research, extraction, formulations, delivery, and distribution of the finished product. This could allow MySpray to maintain high-quality control and enable us to:

 

●Create formulations for clinical trials.

 

●Supply raw materials, standardized extracts, and medicinal compounds that are in high demand for ongoing academic research globally.

 

●Provide finished products direct to consumer.

 

●Offer white label manufacturing.

 

The Company’s year-end is December 31.

 

All figures presented in this report are in US dollars unless stated otherwise. 
XML 16 R8.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES
 6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES

 

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with the FASB’s ASC, which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary MySpray Therapeutics Inc. All intercompany accounts and transactions are eliminated in consolidation.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements.

 

The Company expects to generate operating cash flow that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable.

 

The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all. 

 

Management’s Representation of Interim Consolidated financial statements

 

The accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual consolidated financial statements. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year.

 

Estimates

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these consolidated financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

Cash and Cash Equivalents

 

For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2022, and December 31, 2021, the on-hand cash balances were $82,529 and $9,499, respectively.

 

Inventory

 

Inventory, is stated at the lower of cost or net realizable value with cost determined under the first-in, first-out (“FIFO”) method. As of June 30, 2022, and December 31, 2021, inventory amounted to $40,642 and $-0-, respectively

 

Goodwill and Intangible Assets

 

Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks and product formulations. The useful life of these customer relationships is estimated to be three years.

 

Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess.

 

Revenue Recognition

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The guidance provided in Accounting Standards Codification (“ASC”) Topic 606 (“ASC 606”) requires entities to use a five-step model to recognize revenue by allocating the consideration from contracts to performance obligations on a relative standalone selling price basis. Revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASC 606 also includes Subtopic 340-40, Other Assets and Deferred Costs – Contracts with Customers, which requires the deferral of incremental costs of obtaining a contract with a customer.

 

Foreign Currency Translation

 

The functional and reporting currency of MySpray is the Canadian dollar. Monetary assets denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Average monthly rates are used to translate revenues and expenses.

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income for the respective periods.

 

Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods

 

Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods. Equity transactions are recorded at the historical rate when the transaction occurred. The resulting translation adjustment is reflected as accumulated other comprehensive income, a separate component of stockholders’ equity in the statement of stockholders’ equity.

 

Differences may arise in the amount of bad debt expense, depreciation expense and amortization expense reported in the Company’s operating results as compared to the corresponding change in the allowance for doubtful accounts, accumulated depreciation, and accumulated amortization, respectively, due to foreign currency translation. These translation adjustments are reflected in accumulated other comprehensive income, a separate component of the Company’s stockholders’ equity.

 

Long-lived assets

 

The Company accounts for its long-lived assets in accordance with Financial Accounting Standard Board (“FASB”) ASC 360-10, “Property, Plant and Equipment” which requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of an asset by estimating the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposal value.

 

Income Taxes

 

The Company accounts for income taxes pursuant to FASB ASC Topic 740, Income Taxes. Under FASB ASC Topic 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. The Company maintains a 100% valuation allowance with respect to deferred tax assets, therefore there are no deferred taxes on the Company’s Balance Sheet. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

 

Fair Value Measurement

 

The Company values its convertible notes and amounts due to related partings and short-term loans payable under FASB ASC 820 which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.

 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy are as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities, and listed equities.

 

Level 2 – Valuations for assets and liabilities that can be obtained from readily available pricing sources via independent providers for market transactions involving similar assets or liabilities. The Company’s principal markets for these securities are the secondary institutional markets, and valuations are based on observable market data in those markets.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The Company uses Level 3 to value its derivative instruments.

 

Employee Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718 Compensation-Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest, and will result in a charge to operations.

 

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

 

Subsequent Event

 

The Company evaluated subsequent events through the date when consolidated financial statements are issued for disclosure consideration.

 

Recent Accounting Pronouncements

 

There are no recent accounting pronouncements that have an impact on the Company’s operations

 
XML 17 R9.htm IDEA: XBRL DOCUMENT v3.22.2
GOING CONCERN
 6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 3 – GOING CONCERN

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements. The Company has incurred significant operating losses since its inception. As of June 30, 2022, the Company had a working capital deficit of $916,971 and an accumulated deficit of $377,835.

 

The Company expects to generate operating cash flows that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable.

 

The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all.
XML 18 R10.htm IDEA: XBRL DOCUMENT v3.22.2
BUSINESS ACQUISITION
 6 Months Ended
Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
BUSINESS ACQUISITION

NOTE 4 – BUSINESS ACQUISITION

 

On February 10, 2022, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with MySpray Therapeutics Inc. (“MySpray”), a Saskatchewan, Canadian corporation, Nichol Martinuik (“Martinuik”) and Rachel Martinuik (“R. Martinuik”), the sole officers, directors, and shareholders of MySpray, Qatar Consulting Inc. & Company (“Qatar”), Broadway Creative Consultants Corp. (“Broadway”), and David Lazar (“Lazar”), as the sole officer and director of the Company and the managing member of Activist Investing LLC (“Activist”). Under the Share Exchange Agreement, One Hundred Percent (100%) of the ownership interest of MySpray was exchanged for (i) 51,110,500 shares of common stock of the Company at the Closing, and (ii) an additional 569,889,500 shares of common stock of ADOB, to be issued upon the increase in authorized shares of common stock of ADOB to 700,000,000, each of which is to be issued to Martinuik, R. Martinuik, Qatar, Broadway, and Activist, pro-rata, in accordance with the Share Exchange Agreement. As of the date of this Report, none of the 569,889,500 shares had been issued. The former stockholders of MySpray will acquire a majority of the issued and outstanding common stock as a result of the share exchange transaction. The transaction has been accounted for as a recapitalization of the Company, whereby MySpray is the accounting acquirer.

 

For the acquisition of MySpray the following table summarizes the acquisition date fair value of the consideration paid, identifiable assets acquired and liabilities assumed:

 

Consideration paid

 

     
Common stock, 621,000,000 shares of the Company restricted common stock valued at $0.001 per share  $621,000 
Net liabilities assumed   62,777 
Fair value of total consideration paid  $683,777 

 

Net assets acquired and liabilities assumed

 

      
Cash and cash equivalents  $30,542 
Accounts receivable   595 
Inventory   53,431 
Other assets   1,409 
Total assets  $85,977 
      
Accounts payable and accrued liabilities   117,214 
Government of Canada loan   31,540 
Total liabilities   148,754 
      
Net liabilities assumed  $62,777 

 

The Company has allocated the fair value of the total consideration paid of $547,022 to goodwill and $136,755 to intangible assets with a life of three years. The value of goodwill represents MySpray’s ability to generate profitable operations going forward. Management estimated the provisional fair values of the intangible assets and goodwill at December 31, 2021. The Company’s accounting for the acquisition of MySpray is incomplete. Management is performing a valuation study to calculate the fair value of the acquired intangible assets, which it plans to complete within the one-year measurement period.

 
XML 19 R11.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS
 6 Months Ended
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 5 – INTANGIBLE ASSETS

 

As of June 30, 2022, the balance of intangible assets was $115,895. During the six-month period ended June 30, 2022, the Company recorded $18,948 in amortization expense. As discussed in Note 4, the intangible assets have been valued based on provisional estimates of fair value and are subject to change as the Company completes its valuation assessment by the completion of the one-year measurement period. Amortization for the following fiscal years is estimated to be: 2022 - $36,414; 2023 - $43,697; and 2024 - $43,697, 2025 -$14,983.
XML 20 R12.htm IDEA: XBRL DOCUMENT v3.22.2
RELATED PARTY TRANSACTIONS
 6 Months Ended
Jun. 30, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

The Company has been funded by its executive officers, and officers of its subsidiary. As of June 30, 2022, the balance due to executive officers and a former officer amounted to $299,748 in the form of interest-free demand loans compared to $142,752 during the period ended December 31, 2021. During the six months ended June 30, 2022, the Company’s officers have advanced $24,916 to the Company.

 

Additionally, an officer of MySpray owns the laboratory building that the Company occupies. He rents this facility to MySpray based on a verbal, month-to-month agreement. MySpray pays approximately $26,000 annually in rent. The Company believes that this rent expense is reasonable and comparable to the rent that would be charged to a third party.

 
XML 21 R13.htm IDEA: XBRL DOCUMENT v3.22.2
COMMON STOCK AND COMMON STOCK PAYABLE
 6 Months Ended
Jun. 30, 2022
Common Stock And Common Stock Payable  
COMMON STOCK AND COMMON STOCK PAYABLE

NOTE 7 – COMMON STOCK AND COMMON STOCK PAYABLE

 

On May 5, 2022, the Company filed a Certificate of Amendment with the state of Nevada increasing its authorized shares from 75,000,000 to 700,000,000 shares of $0.001 par value common stock. As of June 30, 2022, and December 31, 2021, a total of 75,000,000 and 23,889,500 shares of common stock were issued and outstanding, respectively.

 

As of the date of this report, the Company had numerous shares issuable as part of the February 10, 2022 Share Exchange and for private placements accepted from investors during the three months ended June 30, 2022. Since the Company has delayed issuing these shares the associated value of the shares has been recorded as a liability on the Company’s, Balance sheet. As of June 30, 2022 and December 31, 2021 the balance of Common Stock Payable was $776,806 and $-0-, respectively.

 

The amount of $776,806 is comprised of the following elements:

 

●569,889,500 shares are issuable pursuant to the terms of the share Exchange Agreement. These shares were valued at a par value of $0.001, or $569,899

 

●During the three months ended June 30, 2022 the Company raised $369,978 from sale of 21,000,000 shares to seven investors. The average sale price of these shares was $0.017618 per share

 

●Additionally, the Company repurchased 24,000,000 shares for $103,333, or an average price of $0.00431

 

None of the above mentioned shares have been issued or retired as of June 30, 2022

 
XML 22 R14.htm IDEA: XBRL DOCUMENT v3.22.2
SUBSEQUENT EVENTS
 6 Months Ended
Jun. 30, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 8 – SUBSEQUENT EVENTS

 

In accordance with the Statement of Financial Accounting Standards (“SFAS”) 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the consolidated financial statements were available to be issued and has determined that it does not have any material subsequent events to disclose in these consolidated financial statements.
XML 23 R15.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Policies)
 6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with the FASB’s ASC, which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary MySpray Therapeutics Inc. All intercompany accounts and transactions are eliminated in consolidation.

 
Going Concern

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements.

 

The Company expects to generate operating cash flow that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable.

 

The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all. 

 
Management’s Representation of Interim Consolidated financial statements

Management’s Representation of Interim Consolidated financial statements

 

The accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual consolidated financial statements. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year.

 
Estimates

Estimates

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these consolidated financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.
Cash and Cash Equivalents

Cash and Cash Equivalents

 

For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2022, and December 31, 2021, the on-hand cash balances were $82,529 and $9,499, respectively.

 
Inventory

Inventory

 

Inventory, is stated at the lower of cost or net realizable value with cost determined under the first-in, first-out (“FIFO”) method. As of June 30, 2022, and December 31, 2021, inventory amounted to $40,642 and $-0-, respectively

 
Goodwill and Intangible Assets

Goodwill and Intangible Assets

 

Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks and product formulations. The useful life of these customer relationships is estimated to be three years.

 

Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess.

 
Revenue Recognition

Revenue Recognition

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The guidance provided in Accounting Standards Codification (“ASC”) Topic 606 (“ASC 606”) requires entities to use a five-step model to recognize revenue by allocating the consideration from contracts to performance obligations on a relative standalone selling price basis. Revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASC 606 also includes Subtopic 340-40, Other Assets and Deferred Costs – Contracts with Customers, which requires the deferral of incremental costs of obtaining a contract with a customer.

 
Foreign Currency Translation

Foreign Currency Translation

 

The functional and reporting currency of MySpray is the Canadian dollar. Monetary assets denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Average monthly rates are used to translate revenues and expenses.

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income for the respective periods.

 

Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods

 

Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods. Equity transactions are recorded at the historical rate when the transaction occurred. The resulting translation adjustment is reflected as accumulated other comprehensive income, a separate component of stockholders’ equity in the statement of stockholders’ equity.

 

Differences may arise in the amount of bad debt expense, depreciation expense and amortization expense reported in the Company’s operating results as compared to the corresponding change in the allowance for doubtful accounts, accumulated depreciation, and accumulated amortization, respectively, due to foreign currency translation. These translation adjustments are reflected in accumulated other comprehensive income, a separate component of the Company’s stockholders’ equity.

 
Long-lived assets

Long-lived assets

 

The Company accounts for its long-lived assets in accordance with Financial Accounting Standard Board (“FASB”) ASC 360-10, “Property, Plant and Equipment” which requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of an asset by estimating the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposal value.

 
Income Taxes

Income Taxes

 

The Company accounts for income taxes pursuant to FASB ASC Topic 740, Income Taxes. Under FASB ASC Topic 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. The Company maintains a 100% valuation allowance with respect to deferred tax assets, therefore there are no deferred taxes on the Company’s Balance Sheet. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

 
Fair Value Measurement

Fair Value Measurement

 

The Company values its convertible notes and amounts due to related partings and short-term loans payable under FASB ASC 820 which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.

 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy are as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities, and listed equities.

 

Level 2 – Valuations for assets and liabilities that can be obtained from readily available pricing sources via independent providers for market transactions involving similar assets or liabilities. The Company’s principal markets for these securities are the secondary institutional markets, and valuations are based on observable market data in those markets.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The Company uses Level 3 to value its derivative instruments.

 
Employee Stock-Based Compensation

Employee Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718 Compensation-Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest, and will result in a charge to operations.

 
Net Loss per Share

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

 
Subsequent Event

Subsequent Event

 

The Company evaluated subsequent events through the date when consolidated financial statements are issued for disclosure consideration.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

There are no recent accounting pronouncements that have an impact on the Company’s operations

 
XML 24 R16.htm IDEA: XBRL DOCUMENT v3.22.2
BUSINESS ACQUISITION (Tables)
 6 Months Ended
Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of cosideration paid
     
Common stock, 621,000,000 shares of the Company restricted common stock valued at $0.001 per share  $621,000 
Net liabilities assumed   62,777 
Fair value of total consideration paid  $683,777 
Schedule of asset and liabilities assumed
      
Cash and cash equivalents  $30,542 
Accounts receivable   595 
Inventory   53,431 
Other assets   1,409 
Total assets  $85,977 
      
Accounts payable and accrued liabilities   117,214 
Government of Canada loan   31,540 
Total liabilities   148,754 
      
Net liabilities assumed  $62,777 
XML 25 R17.htm IDEA: XBRL DOCUMENT v3.22.2
ORGANIZATION AND DESCRIPTION OF THE BUSINESS (Details Narrative) - $ / shares
Jun. 30, 2022
Feb. 10, 2022
Dec. 31, 2021
Oct. 18, 2017
Restructuring Cost and Reserve [Line Items]        
Common stock, shares authorized 700,000,000   700,000,000 75,000,000
Common stock, par value (in Dollars per share) $ 0.001   $ 0.001 $ 0.001
Number of shares issued   644,889,500    
Number of shares outstanding   644,889,500    
Share authorized for capital stock   700,000,000    
Spray [Member]        
Restructuring Cost and Reserve [Line Items]        
Ownership interest   100.00%    
Common stock at Closing   51,110,500    
Common stock to be issued   569,889,500    
Increase in common stock shares authorized   700,000,000    
XML 26 R18.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Details Narrative) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Cash in hand balance $ 82,529 $ 9,499
Inventory $ 40,642 $ (0)
XML 27 R19.htm IDEA: XBRL DOCUMENT v3.22.2
GOING CONCERN (Details Narrative) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Working capital deficit $ 916,971  
Accumulated deficit $ 377,835 $ 183,311
XML 28 R20.htm IDEA: XBRL DOCUMENT v3.22.2
BUSINESS ACQUISITION (Details) - Spray [Member]
Feb. 10, 2022
USD ($)
Business Acquisition [Line Items]  
Common stock, 621,000,000 shares of the Company restricted common stock valued at $0.001 per share $ 621,000
Net liabilities assumed 62,777
Fair value of total consideration paid $ 683,777
XML 29 R21.htm IDEA: XBRL DOCUMENT v3.22.2
BUSINESS ACQUISITION (Details 1) - Spray [Member]
Feb. 10, 2022
USD ($)
Business Acquisition [Line Items]  
Cash and cash equivalents $ 30,542
Accounts receivable 595
Inventory 53,431
Other assets 1,409
Total assets 85,977
Accounts payable and accrued liabilities 117,214
Government of Canada loan 31,540
Total liabilities 148,754
Net liabilities assumed $ 62,777
XML 30 R22.htm IDEA: XBRL DOCUMENT v3.22.2
BUSINESS ACQUISITION (Details Narrative) - USD ($)
 6 Months Ended
Jun. 30, 2022
Feb. 10, 2022
Goodwill [Member]    
Business Acquisition [Line Items]    
Fair value of consideration $ 547,022  
Finite-Lived Intangible Assets [Member]    
Business Acquisition [Line Items]    
Fair value of consideration $ 136,755  
Spray [Member]    
Business Acquisition [Line Items]    
Ownership interest   100.00%
Common stock at Closing   51,110,500
Common stock to be issued   569,889,500
Increase in common stock shares authorized   700,000,000
XML 31 R23.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]          
Intangible assets $ 115,895   $ 115,895  
Amortization expense 11,338 18,948  
2022 36,414   36,414    
2023 43,697   43,697    
2024 43,697   43,697    
2025 $ 14,983   $ 14,983    
XML 32 R24.htm IDEA: XBRL DOCUMENT v3.22.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Related Party Transaction [Line Items]      
Due to related party $ 299,748   $ 142,752
Proceed from related party debt 24,916 $ 31,506  
Spray [Member]      
Related Party Transaction [Line Items]      
Rent payment $ 26,000    
XML 33 R25.htm IDEA: XBRL DOCUMENT v3.22.2
COMMON STOCK AND COMMON STOCK PAYABLE (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Oct. 18, 2017
Offsetting Assets [Line Items]        
Common stock, shares authorized 700,000,000 700,000,000 700,000,000 75,000,000
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001 $ 0.001 $ 0.001
Common stock, shares issued 75,000,000 75,000,000 23,889,500  
Common stock, shares Outstanding 75,000,000 75,000,000 23,889,500  
Common stock payable $ 776,806 $ 776,806 $ (0)  
Share price $ 0.00431 $ 0.00431    
Number of stock repurchased, shares   24,000,000    
Number of stock repurchased, value   $ 103,333    
Seven Investors [Member]        
Offsetting Assets [Line Items]        
Share price $ 0.017618 $ 0.017618    
Number of stock sold, value $ 369,978      
Number of stock sold, shares 21,000,000      
Exchange Agreement [Member]        
Offsetting Assets [Line Items]        
Number of stock issuable, shares   569,889,500    
Share price $ 0.001 $ 0.001    
Number of stock issuable, value   $ 569,899    
XML 34 adorbsinc_10q_htm.xml IDEA: XBRL DOCUMENT 0001726822 2022-01-01 2022-06-30 0001726822 2022-08-01 0001726822 2022-06-30 0001726822 2021-12-31 0001726822 2022-04-01 2022-06-30 0001726822 2021-04-01 2021-06-30 0001726822 2021-01-01 2021-06-30 0001726822 us-gaap:CommonStockMember 2020-12-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001726822 us-gaap:RetainedEarningsMember 2020-12-31 0001726822 2020-12-31 0001726822 us-gaap:CommonStockMember 2021-03-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001726822 us-gaap:RetainedEarningsMember 2021-03-31 0001726822 2021-03-31 0001726822 us-gaap:CommonStockMember 2021-12-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001726822 us-gaap:RetainedEarningsMember 2021-12-31 0001726822 us-gaap:CommonStockMember 2022-03-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001726822 us-gaap:RetainedEarningsMember 2022-03-31 0001726822 2022-03-31 0001726822 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001726822 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001726822 2021-01-01 2021-03-31 0001726822 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001726822 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001726822 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001726822 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001726822 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001726822 2022-01-01 2022-03-31 0001726822 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001726822 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001726822 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001726822 us-gaap:CommonStockMember 2021-06-30 0001726822 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001726822 us-gaap:RetainedEarningsMember 2021-06-30 0001726822 2021-06-30 0001726822 us-gaap:CommonStockMember 2022-06-30 0001726822 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001726822 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001726822 us-gaap:RetainedEarningsMember 2022-06-30 0001726822 2017-10-18 0001726822 adob:SprayMember 2022-02-10 0001726822 2022-02-10 0001726822 us-gaap:GoodwillMember 2022-01-01 2022-06-30 0001726822 us-gaap:FiniteLivedIntangibleAssetsMember 2022-01-01 2022-06-30 0001726822 adob:SprayMember 2022-01-01 2022-06-30 0001726822 adob:ExchangeAgreementMember 2022-01-01 2022-06-30 0001726822 adob:ExchangeAgreementMember 2022-06-30 0001726822 adob:SevenInvestorsMember 2022-04-01 2022-06-30 0001726822 adob:SevenInvestorsMember 2022-06-30 iso4217:USD shares iso4217:USD shares pure 0001726822 false --12-31 2022 Q2 10-Q true 2022-06-30 false 333-222631 ADORBS INC NV 82-3155323 36 Fourth Ave. N Yorkton Saskatchewan CA S3N 2V7 306 563-4123 No No Non-accelerated Filer true false false 75000000 82529 9499 1457 40642 -0 1239 125867 9499 538350 115895 780112 9499 36284 428 776806 -0 229748 142752 1042838 143180 31040 1073878 143180 0.001 0.001 700000000 700000000 75000000 75000000 23889500 23889500 75000 23890 25740 25740 -377835 -183311 -16671 -293766 -133681 780112 9499 69811 134542 23831 39137 45980 95405 53338 19085 101246 33343 140865 168892 11338 18948 205541 19085 289086 33343 -159561 -19085 -193681 -33343 -843 6 -843 12 -843 6 -843 12 -160404 -19079 -194524 -33331 -160404 -19079 -194524 -33331 -0.00 -0.00 -0.00 -0.00 75000000 23889500 63422483 23889500 -160404 -19079 -194524 -33331 -16671 -16671 177075 19079 211195 33331 23889500 23890 25740 -137513 -87883 -14252 -14252 23889500 23890 25740 -151765 -102135 -19079 -19079 23889500 23890 25740 -170844 -121214 23889500 23890 25740 -183311 -133681 51110500 51110 51110 -34120 -34120 75000000 75000 25740 -217431 -116691 -16671 -16671 -160404 -160404 75000000 75000 25740 -16671 -377835 -293766 194524 33331 18948 871 11942 -4440 6 -192829 -33325 -19981 19981 206917 24916 31506 231833 31506 14045 73030 -1819 9499 13593 82529 11774 <p id="xdx_804_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zZbhgtcXz27c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82A_zcTE1FNMKM91">ORGANIZATION AND DESCRIPTION OF THE BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis of Presentation and Organization</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adorbs Inc. is a Nevada corporation. Adorbs was formerly a developmental stage corporation formed to provide organic children’s clothing designed to be cute, comfortable, and trendy. The Company was incorporated under the laws of the State of Nevada on October 18, 2017. On that date, the Company was authorized to issue <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20171018_zLGueOT67p3" title="Common stock, shares authorized">75,000,000</span> shares of common stock at $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20171018_zlBIS0LsFdq6" title="Common stock, par value (in Dollars per share)">0.001</span> par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2022, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with MySpray Therapeutics Inc. (“MySpray”), a Saskatchewan, Canadian corporation, Nichol Martinuik (“Martinuik”) and Rachel Martinuik (“R. Martinuik”), the sole officers, directors, and shareholders of MySpray, Qatar Consulting Inc. &amp; Company (“Qatar”), Broadway Creative Consultants Corp. (“Broadway”), and David Lazar (“Lazar”), as the sole officer and director of the Company and the managing member of Activist Investing LLC (“Activist”). Under the Share Exchange Agreement, One Hundred Percent (<span id="xdx_904_eus-gaap--BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_iI_dp_c20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_zRooWNG9fGub" title="Ownership interest">100</span>%) of the ownership interest of MySpray was exchanged for (i) <span id="xdx_902_ecustom--CommonStockAtClosing_c20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_pdd" title="Common stock at Closing">51,110,500</span> shares of common stock of the Company at the Closing, and (ii) an additional <span id="xdx_90A_ecustom--CommonStockToBeIssued_c20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_pdd" title="Common stock to be issued">569,889,500</span> shares of common stock of ADOB, to be issued upon the increase in authorized shares of common stock of ADOB to <span id="xdx_90B_ecustom--IncreaseInCommonStockSharesAuthorized_c20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_pdd" title="Increase in common stock shares authorized">700,000,000</span>, each of which is to be issued to Martinuik, R. Martinuik, Qatar, Broadway, and Activist, pro-rata, in accordance with the Share Exchange Agreement. The former stockholders of MySpray will acquire a majority of the issued and outstanding common stock as a result of the share exchange transaction. The transaction has been accounted for as a recapitalization of the Company, whereby MySpray is the accounting acquirer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately after completion of such share exchange, the Company will have a total of <span id="xdx_905_eus-gaap--SharesIssued_c20220210_pdd" title="Number of shares issued"><span id="xdx_90D_eus-gaap--SharesOutstanding_c20220210_pdd" title="Number of shares outstanding">644,889,500</span></span> issued and outstanding shares, with authorized share capital for common share of <span id="xdx_909_eus-gaap--CapitalUnitsAuthorized_c20220210_pdd" title="Share authorized for capital stock">700,000,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently, the Company has ceased to fall under the definition of a shell company as defined in Rule 12b-2 under the Exchange Act of 1934, as amended (the “Exchange Act”) and MySpray is now a wholly-owned subsidiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 5, 2022, the Company filed a Certificate of Amendment with the state of Nevada increasing its authorized shares from 75,000,000 to <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20220630_zsKO51TaEFQ8" title="Common stock, shares authorized">700,000,000</span> shares of $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630_zDwThoKFkJUg" title="Common stock, par value (in Dollars per share)">0.001 </span>par value common stock. None of the additional 569,889,500 shares issuable under the terms of the Share Agreement, have been issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will be amending its articles of incorporation to change its name from Adorbs Inc. to Soul Biotechnology Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MySpray creates innovative and clinically developed products for the global natural health community in the areas of immune function, mental health, and pain management and is currently the license holder of 9 Natural Product Numbers (NPN) through the Natural and Non-prescription Health Products Directorate division of Health Canada.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MySpray is preparing to expand formulas to support clinical trials along with the licensing for research and development in the fields of mental health and the impact of treatment protocols with phytonutrients, medicinal mushrooms, and psychedelic compounds under our current “MyShrooms” brand. Also, MySpray is attempting end-to-end capabilities from substrate for growth, genetics, research, extraction, formulations, delivery, and distribution of the finished product. This could allow MySpray to maintain high-quality control and enable us to:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Create formulations for clinical trials.</span></td> </tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supply raw materials, standardized extracts, and medicinal compounds that are in high demand for ongoing academic research globally.</span></td> </tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide finished products direct to consumer.</span></td> </tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="margin-top: 0; margin-bottom: 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer white label manufacturing.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All figures presented in this report are in US dollars unless stated otherwise. </span></p> <p style="margin-top: 0; margin-bottom: 0"/> 75000000 0.001 1 51110500 569889500 700000000 644889500 644889500 700000000 700000000 0.001 <p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_zb0VNZzXT8W2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_82D_zayMM4b2pJhg">SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zwIOPX97dJM1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zWjs9UjWiC22">Basis of presentation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in accordance with the FASB’s ASC, which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary MySpray Therapeutics Inc. All intercompany accounts and transactions are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--GoingConcernPolicyTextBlock_zy4W0MokM19a" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_z7VS0mR3T962">Going Concern</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expects to generate operating cash flow that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--ManagementsRepresentationOfInterimConsolidatedFinancialStatementsPolicyTextBlock_zmHoAOtXd422" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zne1WadFdiM7">Management’s Representation of Interim Consolidated financial statements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual consolidated financial statements. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zVemEwBW9mp3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zuO2nKD8CvG3">Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these consolidated financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSOg9IqqgrA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zw6dWqWIUij7">Cash and Cash Equivalents</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2022, and December 31, 2021, the on-hand cash balances were $<span id="xdx_90D_eus-gaap--Cash_c20220630_pp0p0" title="Cash in hand balance">82,529</span> and $<span id="xdx_90A_eus-gaap--Cash_c20211231_pp0p0" title="Cash in hand balance">9,499</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zy0xtWmjP18b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_z5lseee1PWv4">Inventory</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory, is stated at the lower of cost or net realizable value with cost determined under the first-in, first-out (“FIFO”) method. As of June 30, 2022, and December 31, 2021, inventory amounted to $<span id="xdx_90F_eus-gaap--InventoryNet_c20220630_pp0p0" title="Inventory">40,642</span> and $-<span id="xdx_90C_eus-gaap--InventoryNet_c20211231_pp0p0" title="Inventory">0</span>-, respectively</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zwRwjoT4K602" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zOFbG4wGmG8e">Goodwill and Intangible Assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks and product formulations. The useful life of these customer relationships is estimated to be three years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_zu0wzGSDv5R6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zMlCBiRBIEsj">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i> outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The guidance provided in Accounting Standards Codification (“ASC”) Topic 606 (“ASC 606”) requires entities to use a five-step model to recognize revenue by allocating the consideration from contracts to performance obligations on a relative standalone selling price basis. Revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASC 606 also includes Subtopic 340-40, <i>Other Assets and Deferred Costs – Contracts with Customers</i>, which requires the deferral of incremental costs of obtaining a contract with a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zCoZnRpOBkZf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_z4cLmgIuGVBg">Foreign Currency Translation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional and reporting currency of MySpray is the Canadian dollar. Monetary assets denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Average monthly rates are used to translate revenues and expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income for the respective periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods. Equity transactions are recorded at the historical rate when the transaction occurred. The resulting translation adjustment is reflected as accumulated other comprehensive income, a separate component of stockholders’ equity in the statement of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Differences may arise in the amount of bad debt expense, depreciation expense and amortization expense reported in the Company’s operating results as compared to the corresponding change in the allowance for doubtful accounts, accumulated depreciation, and accumulated amortization, respectively, due to foreign currency translation. These translation adjustments are reflected in accumulated other comprehensive income, a separate component of the Company’s stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxeYS9IKaJ46" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_z7Hy7JmlmNX1">Long-lived assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its long-lived assets in accordance with Financial Accounting Standard Board (“FASB”) ASC 360-10, “Property, Plant and Equipment” which requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of an asset by estimating the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposal value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zRRNlJShLnJc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zuy9VDsBwWb3">Income Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes pursuant to FASB ASC Topic 740, Income Taxes. Under FASB ASC Topic 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. The Company maintains a 100% valuation allowance with respect to deferred tax assets, therefore there are no deferred taxes on the Company’s Balance Sheet. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z6Mce3f19Bb4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_z9R1gBCzTfqk">Fair Value Measurement</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company values its convertible notes and amounts due to related partings and short-term loans payable under FASB ASC 820 which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The three levels of the fair value hierarchy are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities, and listed equities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Valuations for assets and liabilities that can be obtained from readily available pricing sources via independent providers for market transactions involving similar assets or liabilities. The Company’s principal markets for these securities are the secondary institutional markets, and valuations are based on observable market data in those markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The Company uses Level 3 to value its derivative instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zH2PDJGpNu3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zwnLfHX437qd">Employee Stock-Based Compensation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718 Compensation-Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest, and will result in a charge to operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zNhtpUN9sXzi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zv3SmSxYufok">Net Loss per Share</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zJa6kyX9Mage" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zxjjhBMZotfb">Subsequent Event</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated subsequent events through the date when consolidated financial statements are issued for disclosure consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zpgMuzCj4I19" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Recent Accounting Pronouncements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no recent accounting pronouncements that have an impact on the Company’s operations</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zwIOPX97dJM1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zWjs9UjWiC22">Basis of presentation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in accordance with the FASB’s ASC, which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary MySpray Therapeutics Inc. All intercompany accounts and transactions are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--GoingConcernPolicyTextBlock_zy4W0MokM19a" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_z7VS0mR3T962">Going Concern</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expects to generate operating cash flow that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--ManagementsRepresentationOfInterimConsolidatedFinancialStatementsPolicyTextBlock_zmHoAOtXd422" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zne1WadFdiM7">Management’s Representation of Interim Consolidated financial statements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Company uses the same accounting policies in preparing quarterly and annual consolidated financial statements. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zVemEwBW9mp3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zuO2nKD8CvG3">Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these consolidated financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSOg9IqqgrA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zw6dWqWIUij7">Cash and Cash Equivalents</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2022, and December 31, 2021, the on-hand cash balances were $<span id="xdx_90D_eus-gaap--Cash_c20220630_pp0p0" title="Cash in hand balance">82,529</span> and $<span id="xdx_90A_eus-gaap--Cash_c20211231_pp0p0" title="Cash in hand balance">9,499</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 82529 9499 <p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zy0xtWmjP18b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_z5lseee1PWv4">Inventory</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory, is stated at the lower of cost or net realizable value with cost determined under the first-in, first-out (“FIFO”) method. As of June 30, 2022, and December 31, 2021, inventory amounted to $<span id="xdx_90F_eus-gaap--InventoryNet_c20220630_pp0p0" title="Inventory">40,642</span> and $-<span id="xdx_90C_eus-gaap--InventoryNet_c20211231_pp0p0" title="Inventory">0</span>-, respectively</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 40642 0 <p id="xdx_842_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zwRwjoT4K602" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zOFbG4wGmG8e">Goodwill and Intangible Assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks and product formulations. The useful life of these customer relationships is estimated to be three years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_zu0wzGSDv5R6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zMlCBiRBIEsj">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i> outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The guidance provided in Accounting Standards Codification (“ASC”) Topic 606 (“ASC 606”) requires entities to use a five-step model to recognize revenue by allocating the consideration from contracts to performance obligations on a relative standalone selling price basis. Revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. The standard also requires new disclosures regarding the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. ASC 606 also includes Subtopic 340-40, <i>Other Assets and Deferred Costs – Contracts with Customers</i>, which requires the deferral of incremental costs of obtaining a contract with a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zCoZnRpOBkZf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_z4cLmgIuGVBg">Foreign Currency Translation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional and reporting currency of MySpray is the Canadian dollar. Monetary assets denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Average monthly rates are used to translate revenues and expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income for the respective periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities of the Company’s operations are translated into the reporting currency, United States dollars, at the exchange rate in effect at the balance sheet dates. Revenue and expenses are translated at average rates in effect during the reporting periods. Equity transactions are recorded at the historical rate when the transaction occurred. The resulting translation adjustment is reflected as accumulated other comprehensive income, a separate component of stockholders’ equity in the statement of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Differences may arise in the amount of bad debt expense, depreciation expense and amortization expense reported in the Company’s operating results as compared to the corresponding change in the allowance for doubtful accounts, accumulated depreciation, and accumulated amortization, respectively, due to foreign currency translation. These translation adjustments are reflected in accumulated other comprehensive income, a separate component of the Company’s stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxeYS9IKaJ46" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_z7Hy7JmlmNX1">Long-lived assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its long-lived assets in accordance with Financial Accounting Standard Board (“FASB”) ASC 360-10, “Property, Plant and Equipment” which requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of an asset by estimating the future net cash flows expected to result from the asset, including eventual disposition. If the future net cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposal value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zRRNlJShLnJc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zuy9VDsBwWb3">Income Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes pursuant to FASB ASC Topic 740, Income Taxes. Under FASB ASC Topic 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. The Company maintains a 100% valuation allowance with respect to deferred tax assets, therefore there are no deferred taxes on the Company’s Balance Sheet. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z6Mce3f19Bb4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_z9R1gBCzTfqk">Fair Value Measurement</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company values its convertible notes and amounts due to related partings and short-term loans payable under FASB ASC 820 which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The three levels of the fair value hierarchy are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities, and listed equities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Valuations for assets and liabilities that can be obtained from readily available pricing sources via independent providers for market transactions involving similar assets or liabilities. The Company’s principal markets for these securities are the secondary institutional markets, and valuations are based on observable market data in those markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The Company uses Level 3 to value its derivative instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zH2PDJGpNu3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zwnLfHX437qd">Employee Stock-Based Compensation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718 Compensation-Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest, and will result in a charge to operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zNhtpUN9sXzi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zv3SmSxYufok">Net Loss per Share</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zJa6kyX9Mage" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zxjjhBMZotfb">Subsequent Event</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated subsequent events through the date when consolidated financial statements are issued for disclosure consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zpgMuzCj4I19" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Recent Accounting Pronouncements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no recent accounting pronouncements that have an impact on the Company’s operations</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_807_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zcldXqNoCuC" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_82B_zgkkiuhSNY08">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these consolidated financial statements. The Company has incurred significant operating losses since its inception. As of June 30, 2022, the Company had a working capital deficit of $<span id="xdx_908_ecustom--WorkingCapitalDeficit_c20220630_pp0p0" title="Working capital deficit">916,971</span> and an accumulated deficit of $<span id="xdx_908_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_z8ixw5mFWVZ4" title="Accumulated deficit">377,835</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expects to generate operating cash flows that will be sufficient to fund presently anticipated operations although there can be no assurance. This raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing to supplement expected cash flow. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to do so until its operations become profitable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may attempt to raise capital in the near future through the sale of equity or debt financing; however, there can be assurances the Company will be successful in doing so. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/> 916971 -377835 <p id="xdx_803_eus-gaap--BusinessCombinationDisclosureTextBlock_zgIPihn2Tmp" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_82B_z0q0sa5ojwT">BUSINESS ACQUISITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2022, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with MySpray Therapeutics Inc. (“MySpray”), a Saskatchewan, Canadian corporation, Nichol Martinuik (“Martinuik”) and Rachel Martinuik (“R. Martinuik”), the sole officers, directors, and shareholders of MySpray, Qatar Consulting Inc. &amp; Company (“Qatar”), Broadway Creative Consultants Corp. (“Broadway”), and David Lazar (“Lazar”), as the sole officer and director of the Company and the managing member of Activist Investing LLC (“Activist”). Under the Share Exchange Agreement, One Hundred Percent (<span id="xdx_900_eus-gaap--BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_iI_dp_c20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_zqJO8WBCppW" title="Ownership interest">100</span>%) of the ownership interest of MySpray was exchanged for (i) <span id="xdx_906_ecustom--CommonStockAtClosing_iI_c20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_zkpB1mx9MyYf" title="Common stock at Closing">51,110,500</span> shares of common stock of the Company at the Closing, and (ii) an additional <span id="xdx_903_ecustom--CommonStockToBeIssued_iI_c20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_za0RpYayokM2" title="Common stock to be issued">569,889,500</span> shares of common stock of ADOB, to be issued upon the increase in authorized shares of common stock of ADOB to <span id="xdx_90B_ecustom--IncreaseInCommonStockSharesAuthorized_iI_c20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_zNnEzz4hraA8" title="Increase in common stock shares authorized">700,000,000</span>, each of which is to be issued to Martinuik, R. Martinuik, Qatar, Broadway, and Activist, pro-rata, in accordance with the Share Exchange Agreement. As of the date of this Report, none of the 569,889,500 shares had been issued. The former stockholders of MySpray will acquire a majority of the issued and outstanding common stock as a result of the share exchange transaction. The transaction has been accounted for as a recapitalization of the Company, whereby MySpray is the accounting acquirer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the acquisition of MySpray the following table summarizes the acquisition date fair value of the consideration paid, identifiable assets acquired and liabilities assumed:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consideration paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_z6iR49OomxA4" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B7_zLFBaIYrPpTc" style="display: none">Schedule of cosideration paid</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49E_20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_z8FFEzxZUvLa" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--CommonStock621000000SharesOfCompanyRestrictedCommonStockValuedAt0.001PerShare_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Common stock, 621,000,000 shares of the Company restricted common stock valued at $0.001 per share</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">621,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Net liabilities assumed</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">62,777</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--FairValueOfTotalConsiderationPaid_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Fair value of total consideration paid</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">683,777</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zmdhIScsGype" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net assets acquired and liabilities assumed</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z6Re90VNWfb3" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"> <span id="xdx_8B6_z1nOvXW6qcz9" style="display: none">Schedule of asset and liabilities assumed</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_zutl22k3NPR8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zBFdiObzbiE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">30,542</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zq4q0uycSCni" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">595</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_zoBFOK3zqmZk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">53,431</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_zYO1BmHqTsw" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,409</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zpkwk3O5vUHa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">85,977</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zyGDCYmBXZEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">117,214</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_iI_zip48U1k00nk" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Government of Canada loan</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">31,540</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zFJEE4Nky7H2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">148,754</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zUETK0jGjf22" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Net liabilities assumed</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">62,777</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zJ7qcLlQ4jl3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has allocated the fair value of the total consideration paid of $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220101__20220630__us-gaap--FairValueByAssetClassAxis__us-gaap--GoodwillMember_pp0p0" title="Fair value of consideration">547,022</span> to goodwill and $<span id="xdx_907_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220101__20220630__us-gaap--FairValueByAssetClassAxis__us-gaap--FiniteLivedIntangibleAssetsMember_pp0p0" title="Fair value of consideration">136,755</span> to intangible assets with a life of three years. The value of goodwill represents MySpray’s ability to generate profitable operations going forward. Management estimated the provisional fair values of the intangible assets and goodwill at December 31, 2021. The Company’s accounting for the acquisition of MySpray is incomplete. Management is performing a valuation study to calculate the fair value of the acquired intangible assets, which it plans to complete within the one-year measurement period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 51110500 569889500 700000000 <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_z6iR49OomxA4" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B7_zLFBaIYrPpTc" style="display: none">Schedule of cosideration paid</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49E_20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_z8FFEzxZUvLa" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--CommonStock621000000SharesOfCompanyRestrictedCommonStockValuedAt0.001PerShare_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Common stock, 621,000,000 shares of the Company restricted common stock valued at $0.001 per share</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">621,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Net liabilities assumed</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">62,777</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--FairValueOfTotalConsiderationPaid_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Fair value of total consideration paid</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">683,777</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 621000 62777 683777 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z6Re90VNWfb3" style="font: 10pt Times New Roman, Times, Serif; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"> <span id="xdx_8B6_z1nOvXW6qcz9" style="display: none">Schedule of asset and liabilities assumed</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20220210__us-gaap--BusinessAcquisitionAxis__custom--SprayMember_zutl22k3NPR8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zBFdiObzbiE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">30,542</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zq4q0uycSCni" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">595</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_zoBFOK3zqmZk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">53,431</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_zYO1BmHqTsw" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,409</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zpkwk3O5vUHa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">85,977</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zyGDCYmBXZEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">117,214</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_iI_zip48U1k00nk" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Government of Canada loan</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">31,540</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zFJEE4Nky7H2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">148,754</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zUETK0jGjf22" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Net liabilities assumed</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">62,777</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 30542 595 53431 1409 85977 117214 31540 148754 62777 547022 136755 <p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zcCdazj7kby2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_822_zf5VQyhRzNn1">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, the balance of intangible assets was $<span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630_pp0p0" title="Intangible assets">115,895</span>. During the six-month period ended June 30, 2022, the Company recorded $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20220101__20220630_pp0p0" title="Amortization expense">18,948</span> in amortization expense. As discussed in Note 4, the intangible assets have been valued based on provisional estimates of fair value and are subject to change as the Company completes its valuation assessment by the completion of the one-year measurement period. Amortization for the following fiscal years is estimated to be: 2022 - $<span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20220630_pp0p0" title="2022">36,414</span>; 2023 - $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20220630_pp0p0" title="2023">43,697</span>; and 2024 - $<span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20220630_pp0p0" title="2024">43,697</span>, 2025 -$<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20220630_pp0p0" title="2025">14,983</span>.</span></p> 115895 18948 36414 43697 43697 14983 <p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z7RJq28zI9T5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_82B_z4QEumeVQfA9">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has been funded by its executive officers, and officers of its subsidiary. As of June 30, 2022, the balance due to executive officers and a former officer amounted to $<span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220630_z0gwXOtXQhoe" title="Due to related party">299,748</span> in the form of interest-free demand loans compared to $<span id="xdx_902_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zI6PAO6itNKj" title="Due to related party">142,752</span> during the period ended December 31, 2021. During the six months ended June 30, 2022, the Company’s officers have advanced $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20220101__20220630_pp0p0" title="Proceed from related party debt">24,916</span> to the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, an officer of MySpray owns the laboratory building that the Company occupies. He rents this facility to MySpray based on a verbal, month-to-month agreement. MySpray pays approximately $<span id="xdx_90B_eus-gaap--PaymentsForRent_c20220101__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SprayMember_pp0p0" title="Rent payment">26,000</span> annually in rent. The Company believes that this rent expense is reasonable and comparable to the rent that would be charged to a third party.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 299748 142752 24916 26000 <p id="xdx_809_ecustom--CommonStockAndCommonStockPayableTextBlock_zO0d3KJHLVZd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_828_zsGK8JAR6z06">COMMON STOCK AND COMMON STOCK PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 5, 2022, the Company filed a Certificate of Amendment with the state of Nevada increasing its authorized shares from 75,000,000 to <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20220630_z0L9SQgmWWBc" title="Common stock, shares authorized">700,000,000</span> shares of $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630_z4EpzV1uMsv4" title="Common stock, par value (in Dollars per share)">0.001</span> par value common stock. As of June 30, 2022, and December 31, 2021, a total of <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20220630_zr7qN47eW6S9" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20220630_zMrQ0UCBOZ4f" title="Common stock, shares Outstanding">75,000,000</span></span> and <span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zQr9oOGhu932" title="Common stock, shares Outstanding"><span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20211231_z4Fs0cKVwLMg" title="Common stock, shares issued">23,889,500</span></span> shares of common stock were issued and outstanding, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of this report, the Company had numerous shares issuable as part of the February 10, 2022 Share Exchange and for private placements accepted from investors during the three months ended June 30, 2022. Since the Company has delayed issuing these shares the associated value of the shares has been recorded as a liability on the Company’s, Balance sheet. As of June 30, 2022 and December 31, 2021 the balance of Common Stock Payable was $<span id="xdx_903_ecustom--CommonStockPayable_c20220630_pp0p0" title="Common stock payable">776,806</span> and $-<span id="xdx_906_ecustom--CommonStockPayable_c20211231_pp0p0" title="Common stock payable">0</span>-, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of $776,806 is comprised of the following elements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220101__20220630__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember_pdd" title="Number of stock issuable, shares">569,889,500</span> shares are issuable pursuant to the terms of the share Exchange Agreement. These shares were valued at a par value of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_c20220630__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember_pdd" title="Share price">0.001</span>, or $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueOther_c20220101__20220630__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember_pp0p0" title="Number of stock issuable, value">569,899</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended June 30, 2022 the Company raised $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220401__20220630__srt--TitleOfIndividualAxis__custom--SevenInvestorsMember_pp0p0" title="Number of stock sold, value">369,978</span> from sale of <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220401__20220630__srt--TitleOfIndividualAxis__custom--SevenInvestorsMember_pdd" title="Number of stock sold, shares">21,000,000</span> shares to seven investors. The average sale price of these shares was $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_c20220630__srt--TitleOfIndividualAxis__custom--SevenInvestorsMember_pdd" title="Share price">0.017618 </span>per share</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the Company repurchased <span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodShares_c20220101__20220630_pdd" title="Number of stock repurchased, shares">24,000,000</span> shares for $<span id="xdx_900_eus-gaap--StockRepurchasedDuringPeriodValue_c20220101__20220630_pp0p0" title="Number of stock repurchased, value">103,333</span>, or an average price of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_c20220630_pdd" title="Share price">0.00431</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None of the above mentioned shares have been issued or retired as of June 30, 2022</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 700000000 0.001 75000000 75000000 23889500 23889500 776806 0 569889500 0.001 569899 369978 21000000 0.017618 24000000 103333 0.00431 <p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zlYHFIn60xZ6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_822_zPEZPoqOxLIa">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the Statement of Financial Accounting Standards (“SFAS”) 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the consolidated financial statements were available to be issued and has determined that it does not have any material subsequent events to disclose in these consolidated financial statements.</span></p> EXCEL 35 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 36 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 37 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 38 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 63 147 1 false 10 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://adorbs.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://adorbs.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://adorbs.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://adorbs.com/role/StatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) Sheet http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://adorbs.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF THE BUSINESS Sheet http://adorbs.com/role/OrganizationAndDescriptionOfBusiness ORGANIZATION AND DESCRIPTION OF THE BUSINESS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES Sheet http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPolicies SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://adorbs.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - BUSINESS ACQUISITION Sheet http://adorbs.com/role/BusinessAcquisition BUSINESS ACQUISITION Notes 10 false false R11.htm 00000011 - Disclosure - INTANGIBLE ASSETS Sheet http://adorbs.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 11 false false R12.htm 00000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://adorbs.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 00000013 - Disclosure - COMMON STOCK AND COMMON STOCK PAYABLE Sheet http://adorbs.com/role/CommonStockAndCommonStockPayable COMMON STOCK AND COMMON STOCK PAYABLE Notes 13 false false R14.htm 00000014 - Disclosure - SUBSEQUENT EVENTS Sheet http://adorbs.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 14 false false R15.htm 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Policies) Sheet http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Policies) Policies 15 false false R16.htm 00000016 - Disclosure - BUSINESS ACQUISITION (Tables) Sheet http://adorbs.com/role/BusinessAcquisitionTables BUSINESS ACQUISITION (Tables) Tables http://adorbs.com/role/BusinessAcquisition 16 false false R17.htm 00000017 - Disclosure - ORGANIZATION AND DESCRIPTION OF THE BUSINESS (Details Narrative) Sheet http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative ORGANIZATION AND DESCRIPTION OF THE BUSINESS (Details Narrative) Details http://adorbs.com/role/OrganizationAndDescriptionOfBusiness 17 false false R18.htm 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Details Narrative) Sheet http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Details Narrative) Details http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies 18 false false R19.htm 00000019 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://adorbs.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://adorbs.com/role/GoingConcern 19 false false R20.htm 00000020 - Disclosure - BUSINESS ACQUISITION (Details) Sheet http://adorbs.com/role/BusinessAcquisitionDetails BUSINESS ACQUISITION (Details) Details http://adorbs.com/role/BusinessAcquisitionTables 20 false false R21.htm 00000021 - Disclosure - BUSINESS ACQUISITION (Details 1) Sheet http://adorbs.com/role/BusinessAcquisitionDetails1 BUSINESS ACQUISITION (Details 1) Details http://adorbs.com/role/BusinessAcquisitionTables 21 false false R22.htm 00000022 - Disclosure - BUSINESS ACQUISITION (Details Narrative) Sheet http://adorbs.com/role/BusinessAcquisitionDetailsNarrative BUSINESS ACQUISITION (Details Narrative) Details http://adorbs.com/role/BusinessAcquisitionTables 22 false false R23.htm 00000023 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://adorbs.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://adorbs.com/role/IntangibleAssets 23 false false R24.htm 00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://adorbs.com/role/RelatedPartyTransactions 24 false false R25.htm 00000025 - Disclosure - COMMON STOCK AND COMMON STOCK PAYABLE (Details Narrative) Sheet http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative COMMON STOCK AND COMMON STOCK PAYABLE (Details Narrative) Details http://adorbs.com/role/CommonStockAndCommonStockPayable 25 false false All Reports Book All Reports adorbsinc_10q.htm adob-20220630.xsd adob-20220630_cal.xml adob-20220630_def.xml adob-20220630_lab.xml adob-20220630_pre.xml adorbsinc_ex31-1.htm adorbsinc_ex32-1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 40 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "adorbsinc_10q.htm": { "axisCustom": 0, "axisStandard": 6, "contextCount": 63, "dts": { "calculationLink": { "local": [ "adob-20220630_cal.xml" ] }, "definitionLink": { "local": [ "adob-20220630_def.xml" ] }, "inline": { "local": [ "adorbsinc_10q.htm" ] }, "labelLink": { "local": [ "adob-20220630_lab.xml" ] }, "presentationLink": { "local": [ "adob-20220630_pre.xml" ] }, "schema": { "local": [ "adob-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 237, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 47, "http://xbrl.sec.gov/dei/2022": 5, "total": 52 }, "keyCustom": 14, "keyStandard": 133, "memberCustom": 3, "memberStandard": 6, "nsprefix": "adob", "nsuri": "http://adorbs.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://adorbs.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - BUSINESS ACQUISITION", "role": "http://adorbs.com/role/BusinessAcquisition", "shortName": "BUSINESS ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - INTANGIBLE ASSETS", "role": "http://adorbs.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://adorbs.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "adob:CommonStockAndCommonStockPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - COMMON STOCK AND COMMON STOCK PAYABLE", "role": "http://adorbs.com/role/CommonStockAndCommonStockPayable", "shortName": "COMMON STOCK AND COMMON STOCK PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "adob:CommonStockAndCommonStockPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - SUBSEQUENT EVENTS", "role": "http://adorbs.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Policies)", "role": "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - BUSINESS ACQUISITION (Tables)", "role": "http://adorbs.com/role/BusinessAcquisitionTables", "shortName": "BUSINESS ACQUISITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - ORGANIZATION AND DESCRIPTION OF THE BUSINESS (Details Narrative)", "role": "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "shortName": "ORGANIZATION AND DESCRIPTION OF THE BUSINESS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-02-10", "decimals": "INF", "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Details Narrative)", "role": "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R19": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "adob:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - GOING CONCERN (Details Narrative)", "role": "http://adorbs.com/role/GoingConcernDetailsNarrative", "shortName": "GOING CONCERN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "adob:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets (Unaudited)", "role": "http://adorbs.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-02-10_custom_SprayMember", "decimals": "0", "first": true, "lang": null, "name": "adob:CommonStock621000000SharesOfCompanyRestrictedCommonStockValuedAt0.001PerShare", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - BUSINESS ACQUISITION (Details)", "role": "http://adorbs.com/role/BusinessAcquisitionDetails", "shortName": "BUSINESS ACQUISITION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-02-10_custom_SprayMember", "decimals": "0", "first": true, "lang": null, "name": "adob:CommonStock621000000SharesOfCompanyRestrictedCommonStockValuedAt0.001PerShare", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-02-10_custom_SprayMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - BUSINESS ACQUISITION (Details 1)", "role": "http://adorbs.com/role/BusinessAcquisitionDetails1", "shortName": "BUSINESS ACQUISITION (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-02-10_custom_SprayMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-012022-06-30_us-gaap_GoodwillMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - BUSINESS ACQUISITION (Details Narrative)", "role": "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative", "shortName": "BUSINESS ACQUISITION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-012022-06-30_us-gaap_GoodwillMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "role": "http://adorbs.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R24": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - COMMON STOCK AND COMMON STOCK PAYABLE (Details Narrative)", "role": "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative", "shortName": "COMMON STOCK AND COMMON STOCK PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "adob:CommonStockAndCommonStockPayableTextBlock", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)", "role": "http://adorbs.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations (Unaudited)", "role": "http://adorbs.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-04-012022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)", "role": "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit", "shortName": "Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)", "role": "http://adorbs.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF THE BUSINESS", "role": "http://adorbs.com/role/OrganizationAndDescriptionOfBusiness", "shortName": "ORGANIZATION AND DESCRIPTION OF THE BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES", "role": "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - GOING CONCERN", "role": "http://adorbs.com/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "adorbsinc_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 10, "tag": { "adob_BasicAndDilutedLossPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted loss per share" } } }, "localname": "BasicAndDilutedLossPerShare", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "adob_ChangeInExchangeRates": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Change in exchange rates" } } }, "localname": "ChangeInExchangeRates", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "adob_CommonStock621000000SharesOfCompanyRestrictedCommonStockValuedAt0.001PerShare": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock, 621,000,000 shares of the Company restricted common stock valued at $0.001 per share" } } }, "localname": "CommonStock621000000SharesOfCompanyRestrictedCommonStockValuedAt0.001PerShare", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "adob_CommonStockAndCommonStockPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMON STOCK AND COMMON STOCK PAYABLE" } } }, "localname": "CommonStockAndCommonStockPayableTextBlock", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayable" ], "xbrltype": "textBlockItemType" }, "adob_CommonStockAtClosing": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock at Closing" } } }, "localname": "CommonStockAtClosing", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adob_CommonStockPayable": { "auth_ref": [], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock payable" } } }, "localname": "CommonStockPayable", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/BalanceSheets", "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adob_CommonStockToBeIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock to be issued" } } }, "localname": "CommonStockToBeIssued", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adob_DisclosureCommonStockAndCommonStockPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock And Common Stock Payable" } } }, "localname": "DisclosureCommonStockAndCommonStockPayableAbstract", "nsuri": "http://adorbs.com/20220630", "xbrltype": "stringItemType" }, "adob_ExchangeAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exchange Agreement [Member]" } } }, "localname": "ExchangeAgreementMember", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "adob_FairValueOfTotalConsiderationPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of total consideration paid" } } }, "localname": "FairValueOfTotalConsiderationPaid", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "adob_GoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Going Concern" } } }, "localname": "GoingConcernPolicyTextBlock", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adob_IncreaseInCommonStockSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase in common stock shares authorized" } } }, "localname": "IncreaseInCommonStockSharesAuthorized", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adob_ManagementsRepresentationOfInterimConsolidatedFinancialStatementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Management\u2019s Representation of Interim Consolidated financial statements" } } }, "localname": "ManagementsRepresentationOfInterimConsolidatedFinancialStatementsPolicyTextBlock", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adob_ProceedsFromCommonStockPayable": { "auth_ref": [], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "ProceedsFromCommonStockPayable", "verboseLabel": "Common stock payable" } } }, "localname": "ProceedsFromCommonStockPayable", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adob_SevenInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Seven Investors [Member]" } } }, "localname": "SevenInvestorsMember", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "adob_SprayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spray [Member]" } } }, "localname": "SprayMember", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails", "http://adorbs.com/role/BusinessAcquisitionDetails1", "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "adob_WeightedAverageNumberOfSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstanding", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "adob_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital deficit.", "label": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://adorbs.com/20220630", "presentation": [ "http://adorbs.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r308", "r310", "r311" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://adorbs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r124", "r241" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accrued payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r125", "r126" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r16", "r34", "r36", "r37", "r278", "r290", "r291" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r33", "r37", "r44", "r45", "r46", "r79", "r80", "r81", "r212", "r235", "r286", "r287" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r14", "r247" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r79", "r80", "r81", "r178", "r179", "r180", "r218" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r65", "r140", "r142" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://adorbs.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of intangible assets", "verboseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/IntangibleAssetsDetailsNarrative", "http://adorbs.com/role/StatementsOfCashFlows", "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r10", "r75", "r110", "r113", "r119", "r128", "r154", "r155", "r156", "r158", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r207", "r213", "r223", "r245", "r247", "r267", "r276" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r23", "r75", "r128", "r154", "r155", "r156", "r158", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r207", "r213", "r223", "r245", "r247" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r170", "r171", "r199" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails", "http://adorbs.com/role/BusinessAcquisitionDetails1", "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r170", "r171", "r194", "r195", "r199" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails", "http://adorbs.com/role/BusinessAcquisitionDetails1", "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails", "http://adorbs.com/role/BusinessAcquisitionDetails1", "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r201", "r202", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Fair value of consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r200", "r204" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "BUSINESS ACQUISITION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Total assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "verboseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r196", "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "verboseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Total liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r196", "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Net liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails", "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Government of Canada loan" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.", "label": "Ownership interest" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_CapitalUnitsAuthorized": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies.", "label": "Share authorized for capital stock" } } }, "localname": "CapitalUnitsAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_Cash": { "auth_ref": [ "r8", "r247", "r292", "r293" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "verboseLabel": "Cash in hand balance" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets", "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r59", "r67", "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents, end of year", "periodStartLabel": "Cash and cash equivalents, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r59", "r226" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r79", "r80", "r218" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheetsParenthetical", "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheetsParenthetical", "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative", "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheetsParenthetical", "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r13", "r167" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheetsParenthetical", "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r13", "r247" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, Par Value $0.001, 700,000,000 shares authorized, 75,000,000 and 23,889,500 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r39", "r41", "r42", "r50", "r273", "r283" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "negatedTotalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive loss:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r52", "r75", "r128", "r154", "r155", "r156", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r223" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of sales" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r24", "r77", "r157", "r159", "r160", "r164", "r165", "r166", "r239" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r77", "r157", "r159", "r160", "r164", "r165", "r166", "r239", "r270", "r281" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to related party" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r96", "r97" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Loss per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": { "auth_ref": [ "r226" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate rates on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r44", "r45", "r46", "r79", "r80", "r81", "r83", "r88", "r90", "r99", "r129", "r167", "r168", "r178", "r179", "r180", "r190", "r191", "r218", "r227", "r228", "r229", "r230", "r231", "r233", "r235", "r286", "r287", "r288" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Class of asset." } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r220", "r222" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-Lived Intangible Assets [Member]" } } }, "localname": "FiniteLivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r141", "r252" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets", "http://adorbs.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r53" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r9", "r134", "r135", "r136", "r138", "r247", "r266" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r137", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Member]" } } }, "localname": "GoodwillMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r51", "r75", "r110", "r112", "r115", "r118", "r120", "r128", "r154", "r155", "r156", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r223" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r145", "r146" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r48", "r110", "r112", "r115", "r118", "r120", "r265", "r271", "r275", "r284" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss from operations before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r76", "r89", "r90", "r109", "r185", "r192", "r193", "r285" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r43", "r183", "r184", "r186", "r187", "r188", "r189" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r61", "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Cash paid for income tax expense" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r64" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accrued payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r64" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r64" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r64" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r274" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income (expense)" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r57", "r60", "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest expense" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r21", "r247" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets", "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r7", "r20", "r72", "r98", "r130", "r131", "r132", "r250" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r26", "r75", "r114", "r128", "r154", "r155", "r156", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r208", "r213", "r214", "r223", "r245", "r246" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r19", "r75", "r128", "r223", "r247", "r269", "r280" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u2019 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r27", "r75", "r128", "r154", "r155", "r156", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r208", "r213", "r214", "r223", "r245", "r246", "r247" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r59" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r59" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r59", "r63", "r66" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r38", "r40", "r46", "r49", "r66", "r75", "r82", "r84", "r85", "r86", "r87", "r89", "r90", "r93", "r110", "r112", "r115", "r118", "r120", "r128", "r154", "r155", "r156", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r219", "r223", "r272", "r282" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r84", "r85", "r86", "r87", "r91", "r92", "r94", "r95", "r110", "r112", "r115", "r118", "r120" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "negatedLabel": "Net loss" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r54" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expenses), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r29", "r30" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r110", "r112", "r115", "r118", "r120" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r3", "r217" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "ORGANIZATION AND DESCRIPTION OF THE BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/OrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "auth_ref": [ "r32", "r35", "r224", "r225", "r232" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r205", "r206", "r211" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Net loss" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expenses)" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r11", "r268", "r277" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Government loans" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r22", "r133" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid and other assets" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Rent payment" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r55" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisition of a business net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r56" ], "calculation": { "http://adorbs.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from related party loans", "verboseLabel": "Proceed from related party debt" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r295", "r296" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r38", "r40", "r46", "r58", "r75", "r82", "r89", "r90", "r110", "r112", "r115", "r118", "r120", "r128", "r154", "r155", "r156", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r205", "r209", "r210", "r215", "r216", "r219", "r223", "r275" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r169", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r169", "r238", "r242", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r236", "r237", "r239", "r243", "r244" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r15", "r168", "r247", "r279", "r289", "r291" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets", "http://adorbs.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r79", "r80", "r81", "r83", "r88", "r90", "r129", "r178", "r179", "r180", "r190", "r191", "r218", "r286", "r288" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r73", "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r47", "r75", "r107", "r108", "r111", "r116", "r117", "r121", "r122", "r123", "r128", "r154", "r155", "r156", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r223", "r275" ], "calculation": { "http://adorbs.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "verboseLabel": "Revenue, net" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue, net" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Number of stock sold, value" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Number of stock sold, shares" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.", "label": "Schedule of cosideration paid" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r194", "r195", "r199" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionDetails", "http://adorbs.com/role/BusinessAcquisitionDetails1", "http://adorbs.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of asset and liabilities assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BusinessAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r240", "r242" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r147", "r148", "r149", "r150", "r151", "r152", "r153" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r172", "r173", "r174", "r175", "r176", "r177", "r181", "r182" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Employee Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Number of shares issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Share price" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Number of shares outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginnig balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative", "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r71", "r78" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING ASSUMPTIONS AND POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r28", "r44", "r45", "r46", "r79", "r80", "r81", "r83", "r88", "r90", "r99", "r129", "r167", "r168", "r178", "r179", "r180", "r190", "r191", "r218", "r227", "r228", "r229", "r230", "r231", "r233", "r235", "r286", "r287", "r288" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r79", "r80", "r81", "r99", "r251" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r12", "r13", "r168" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Shares issued with acquisition of MySpray, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Number of stock issuable, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r28", "r167", "r168" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Shares issued with acquisition of MySpray" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Number of stock issuable, value" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r12", "r13", "r167", "r168" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Number of stock repurchased, shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r12", "r13", "r167", "r168" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Number of stock repurchased, value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r13", "r17", "r18", "r75", "r127", "r128", "r223", "r247" ], "calculation": { "http://adorbs.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets", "http://adorbs.com/role/StatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reporting subsequent events.", "label": "Subsequent Event" } } }, "localname": "SubsequentEventsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r248", "r249" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/CommonStockAndCommonStockPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r100", "r101", "r102", "r103", "r104", "r105", "r106" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://adorbs.com/role/SummaryOfSignificantAccountingAssumptionsAndPoliciesPolicies" ], "xbrltype": "textBlockItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r249": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16(a))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r297": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r298": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r299": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312" }, "r300": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r301": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r302": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r303": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r304": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r305": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r306": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r307": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r308": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r309": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r310": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r311": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r312": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r313": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r314": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r315": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r316": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" } }, "version": "2.1" } ZIP 41 0001829126-22-014926-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001829126-22-014926-xbrl.zip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end